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Palladin is a novel actin microfilament associated protein, which together with 
myotilin and myopalladin forms a novel cytoskeletal IgC2 domain protein family. 
Whereas the expression of myotilin and myopalladin is limited mainly to striated muscle, 
palladin is widely expressed in both epithelial and mesenchymal tissues, including heart 
and the nervous system. Palladin has a complex genetic structure and it is expressed as 
several different sized and structured splice variants, which also display differences in 
their expression pattern and interactions. In muscle cells, all the family members localize 
to the sarcomeric Z-disc, and in non-muscle cells palladin also localizes to the stress-fiber-
dense regions, lamellipodia, podosomes and focal adhesions. A common feature of this 
protein family is the binding to α-actinin, but other interactions are mostly unique to each 
member. Palladin has been shown to interact with several proteins, including VASP, 
profilin, Eps8, LASP-1 and LPP. Its domain structure, lack of enzymatic activity and 
multiple interactions define it as a molecular scaffolding protein, which links together 
proteins with different functional modalities into large complexes. Palladin has an 
important role in cytoskeletal regulation, particularly in stress fiber formation and 
stabilization. This assumption is supported by several experimental results. First, over-
expression of palladin in non-muscle cells results in rapid reorganization of the actin 
cytoskeleton and formation of thick actin bundles. Second, the knock-down of palladin 
with anti-sense and siRNA techniques or knock-out by genetic methods leads to defective 
stress fiber formation. Furthermore, palladin is usually up-regulated in situations requiring 
a highly organized cytoskeleton, such as differentiation of dendritic cells, trophoblasts and 
myofibroblasts, and activation of astrocytes during glial scar formation. The protein 
family members have also direct disease linkages; myotilin missense mutations are the 
cause of LGMD1A and myofibrillar myopathy. Palladin mutations and polymorphisms, 
on the other hand, have been linked to hereditary pancreatic cancer and myocardial 
infarction, respectively. 
In this study we set out to characterize human palladin. We identified several palladin 
isoforms, studied their tissue distribution and sub-cellular localization. Four novel 
interaction partners were identified; ezrin, ArgBP2, SPIN90 and Src-kinase.The 
previously identified interaction between palladin and α-actinin was also characterized in 
detail. All the identified new binding partners are actin cytoskeleton associated proteins; 
ezrin links the plasma membrane to the cytoskeleton, ArgBP2 and SPIN90 localize, 
among other structures, to the lamellipodia and in cardiomyocytes to the Z-disc. Src is a 
transforming tyrosine kinase, which besides its role in oncogenesis has also important 
cytoskeletal associations. We also studied palladin in myofibroblasts, which are 
specialized cells involved in diverse physiological and pathological processes, such as 
wound healing and tissue fibrosis. We demonstrated that palladin is up-regulated during 
the differentiation of myofibroblasts in an isoform specific manner, and that this up-
regulation is induced by TGF-β via activation of both the SMAD and MAPK signalling 
cascades.  
In summary, the results presented here describe the initial characterization of human 
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Review of the literature 
1. The cytoskeleton 
The cytoskeleton of eukaryotic cells is a complex meshwork of three major components – 
microtubules, intermediate filaments and actin microfilaments. These structures are 
assembled from soluble precursors under precise spatial and temporal control during 
multiple cellular processes. The filament systems are cross- and interlinked by binding 
proteins, which also link other proteins with different functional modalities to the 
cytoskeleton. The cytoskeleton is required for achieving/maintaining cellular structure and 
polarity, and is also indispensable for cell movement and cell division. 
Of the three components of the cytoskeleton, actin microfilaments are the smallest, ca. 
8 nm in diameter. Microtubules are the largest, having a diameter of about 25 nm, and as 
the name indicates, intermediate filaments have a diameter between that of microfilaments 
and microtubules, approx. 10 nm (reviewed in Insall and Machesky, 2001).  
1.1. Microtubules and intermediate filaments 
Microtubules are built from dimers of two 50-kDa proteins, α- and β-tubulin. The 
dimers polymerize end to end, giving the filament polarity. The actual tubules are 
composed of 13 protofilaments encircling a hollow core, resulting in a rigid structure, 
contrary to the other filament systems. Microtubules mostly occupy the perinuclear region 
of the cell. They originate from a central structure called the centrosome and radiate 
outward, only occasionally extending to the edge of the cell. When the cells divide, the 
mitotic spindle is mainly composed of microtubules, the role of which in the process is 
high-lighted by the cytotoxic drugs, the taxanes, which prevent cell division by stabilizing 
the microtubules and preventing their normal function. Microtubules form also the core 
structure of the cilia and participate in the movement of these structures (reviewed in 
Amos, 2005) (Joshi, 1998).  
In intracellular trafficking, vesicles and organelles move along microtubules, and 
therefore use specific motor proteins such as kinesin. For example in neuronal axons, 
which can be as long as 1m, microtubule motors shuttle material between the cell body 
and the axonal terminus. This movement is directed by the polarity of the tubule and the 
specific orientation of the motor protein; for instance most kinesins move only from the 
central minus end of the tubule to the peripheral plus end (reviewed in Baas and Karabay, 
2005).  
Intermediate filaments are also composed of monomers originating from a large family 
of related genes (reviewed in Foisner, 2001). The monomers are not uniform but have a 
rather large range of sizes from ca 40 kDa to more than 100 kDa (Strelkov et al., 2003). 
The largest group of these genes consists of keratins, which are mostly expressed in 
epithelial cells in a tissue-specific manner. The family also includes neuron-specific 






in mesenchymal cells and tissues. In the filament assembly the monomers organize to a 
rope-like structure, with several monomers intertwined. The resulting structure has 
considerable tensile strength but lacks obvious polarity (Kreplak and Fudge, 2007). A 
specific group of intermediate filaments, called lamins, make up the nuclear lamina during 
cell division. The filaments usually extend throughout the cell, forming a complex 
meshwork. The individual filaments are rather stable structures which do not go through 
constant remodelling like the actin microfilaments and microtubules. This notion has led 
to the assumption that their main function is to retain cell structure, particularly under 
physical stress.  
1.2. Actin cytoskeleton 
1.2.1 Organization of actin cytoskeleton 
The core structures of actin cytoskeleton, microfilaments, are composed of only a 
single subunit, i.e. actin. Actin monomeres are referred to as G-actin (for globular) and the 
filamentous form F-actin. Humans have six actin isoforms coded by separate genes, which 
are divided into three groups: alpha (α), beta (β) and gamma (γ). α-actins are expressed 
mainly in muscle cells (α-skeletal, α-smooth muscle, α-cardiac), whereas β- and γ- 
isoforms are found in non-muscle cells (β- and γ1-cytoplasmic). Each actin monomer has 
a molecular weight of 42 kDa and contains a bound adenine nucleotide, either adenosine 
triphosphate (ATP) or adenosine diphosphate (ADP). During polymerization, actin sub-
units assemble head-to-tail, and in the process ATP is usually hydrolyzed to ADP. F-actin 
forms a simple helix and has a defined polarity which is important for its cellular function 
(reviewed in Insall and Machesky, 2001; Ampe and Vandekerckhove, 2005). The 
individual actin filaments are rather flexible and do not possess much tensile strength. In 
living cells they are therefore linked together into multiple higher order structures by 
actin-binding proteins (ABPs, see section 2) (Ayscough, 1998). Several types of actin 
structures with different functional properties have been described. 
The lamellipodium is defined as the thin (~0.2 μm) membrane protrusion at the front 
of spreading and migrating cells (a.k.a. leading edge) (Small et al., 2002) (Figure 1). The 
membrane is remodelled and relocated by the force generated by the actin polymerization 
underneath it. Lamellipodia contain a highly dynamic mesh of actin filaments joined to 
each other at a precise angle. One of the most important ABPs involved in the 
organization of the actin network is the Arp2/3 complex (Ayscough, 1998; Small, 1994; 
Small et al., 2002). The complex binds to the sides of existing filaments and initiates 
growth (nucleates) of new filaments at a distinctive 70 degree angle, thus creating a 
branched actin network. Other actin-associated proteins localizing to lamellipodia are for 
instance cortactin, filamin, SPIN90, α-actinin, and palladin (Goicoechea et al., 2006; Kim 
et al., 2006; Small et al., 2002). The lamellipodium is a very dynamic structure in which 






place during cell movement. Both endo- and exocytosis also takes place in the 
lamellipodia. 
 
Another actin-based cellular structure is the stress fiber (reviewed in Vallenius;2004 
academic dissertation). Stress fibers are thick bundles traversing the cell (Figure 1).In 
these structures individual actin filaments are bundled together through cross-linking 
proteins. They have the ability to contract, and via adhesions transmit the generated 
energy to the ECM; they can thus be considered to be the non-muscle equivalent of the 
sarcomere (Small and Gimona, 1998). The structure of the fibers is not uniform and they 
contain regularly spaced thickenings called dense bodies. These structures resemble the Z-
discs of the sarcomere (Small and Gimona, 1998). Dense bodies are composed of several 
ABPs (e.g. α-actinin), scaffolding proteins and probably also transiently include proteins 
involved in signalling, such as kinases. 
According to an elegant study by Hotulainen and Lappalainen (2006), there are two 
distinct ways in which stress fibers are formed. The authors divided stress fibers into two 
categories, i.e., dorsal stress fibers and transverse arcs. They showed that dorsal fibers are 
connected to the ECM at one end by focal adhesions and are formed by formin 
(mDia1/DRF1) -mediated actin polymerization at the contact sites. The transverse arcs 
which are not directly attached to the ECM are, on the other hand, generated by endwise 
annealing of myosin bundles and Arp2/3-nucleated actin bundles at the lamella. Both of 
these fiber types can be converted to ventral stress fibers, which are connected to focal 
adhesions at both ends. 
The formation of stress fibers also requires, as the name implies, physical stress 
applied to the cells. Under normal conditions in vivo most cells are protected against such 
forces by the three-dimensional ECM, and only a few cell types, endothelial cells for 
instance, are under constant direct physical stress. When the support of the ECM is 
compromised, e.g. by a wound in the dermis, the cells react rapidly to this new situation 
by forming stress fibers. This is also true for cells that have to adapt to a two-dimensional 
growth environment on tissue culture dishes (reviewed in Vallenius; 2004 academic 
dissertation). Once formed, the stress fibers are able to contract as shown directly in in 
vitro experiments and also indirectly in in vivo studies on wound healing. In vitro 
fibroblasts grown in collagen lattices attached to the bottom of culture dishes develop 
stress fibers and contract rapidly once the tension is relieved upon detachment. On the 
other hand, fibroblasts grown on floating lattices do not form stress fibers and therefore 
fail to contract (Tomasek et al., 2002). In vivo specialized fibroblastic cells called 
myofibroblasts are responsible for generating the force needed to contract granulation 
tissue during wound healing (Hinz et al., 2001; Hinz and Gabbiani, 2003b, see Chapter 4). 
Myofibroblasts have highly developed focal adhesions and stress fibers which, in addition 
to other actin isoforms, contain also α-SMA (Hinz et al., 2001; Hinz and Gabbiani, 2003a; 
Hinz et al., 2003). SMA has been shown to enhance the contraction of these cells by a yet 




Figure 1. A) A simplified illustration of different actin-based cellular structures.B) In a lateral 
view, the orientation of some of these strucutres is shown. As the name implies the dorsal 
ruffles are located on the dorsal surface of the cell and project up-ward. On the contrary, the 
podosomes are found on the ventral surface where they attach the cell to the extra-cellular 
matrix. 
1.2.2. Actin cytoskeleton of striated muscle 
The actin cytoskeleton of striated muscle cells, myocytes and cardiomyocytes, is 
organized in repeated ordered arrays of thin and thick filaments which form the contractile 
units, sarcomeres. Different zones of the sarcomere are named as either bands or lines: the 
A-band is composed of myosin and myosin-binding proteins, whereas the major 
component of the I-band is actin. The M-line is located in the middle of the A-band, and 
the Z-disc forms the centre of the I-band. One sarcomere unit is defined as the area 
between two Z-discs (Clark et al., 2002) (Figure 2). 
The adjacent sarcomeres are connected by the Z-discs, composed of several proteins 
with multiple functional modalities (reviewed in Salminkangas, P; 2001 academic 
dissertation, Klaavuniemi, T; 2006 academic dissertation). In the cell periphery, Z-discs 
are connected to the plasma membrane via specialized multiprotein complexes called 






to these multiple connections the Z-disc is a primary conduit of the force generated by 
sarcomere contraction. One of the major components of the Z-discs is α-actinin, which 
crosslinks the thin actin filaments. The giant proteins, titin and nebulin, are also partially 
located in the Z-discs (Clark et al., 2002). In addition to its structural function the Z-disc is 
nowadays also considered to be a platform for multiple signaling cascades, and it can act 
as a direct stretch sensor (Epstein and Davis, 2003) (Frank et al., 2006). Some of the Z-
disc components can shuttle between the sarcoplasm and the nucleus, transmitting signals 
and probably regulating gene transcription (Clark et al., 2002; Frank et al., 2006).  
Although skeletal and cardiac muscles are closely related, there are also some 
differences between them. Cardiac muscle is composed of branched muscle fibers which 
are connected to one another through intercalated discs. This structure is unique to 
cardiomyocytes and is not found in skeletal myocytes. There are three types of membrane 
junctions within an intercalated disc: fascia adherens, macula adherens, and gap junctions. 
Actin filaments, and hence the sarcomere, are anchored to the membrane via fascia 
adherens. Macula adherens (a.k.a desmosome) provides structural stability during 
contraction by linking together the intermediate filaments of adjoining cells. Gap junctions 
pass ions between the cells and thus allow the spread of action potentials causing 
depolarization of the heart muscle (Perriard et al, 2003).  
 
 







2. Actin-associated proteins 
The structure and functions of the actin cytoskeleton are regulated by a large number 
of actin-binding proteins (ABP). These proteins do not form a single uniform protein 
family, since both proteins with and without enzymatic activity can bind directly to actin. 
In a recent review Dos Remedios et al. (2003) suggested that ABPs could be divided into 
seven groups. 1) Proteins binding to monomeric G-actin and preventing polymerization 
(thymosin 4). 2) Depolymerizing proteins which convert F- to G-actin (cofilin). 3) 
Filament end-binding proteins; these proteins bind either to the pointed end 
(tropomodulin) or the barbed end (CapZ) capping the actin filament and preventing the 
exchange of monomers. 4) Filament severing proteins which cut pre-existing actin 
filaments into shorter fragments (gelsolin). 5) Actin cross-linking proteins, which contain 
at least two F-actin binding sites; these proteins can bundle actin filaments or form 
branched filament networks (the Arp2/3 complex). 6) Stabilizing proteins which bind to 
filaments and prevent depolymerization (tropomyosin). 7) Motor proteins which move 
along actin filaments (myosin). Actin nucleating proteins such as the Arp2/3 complex 
form in fact an additional 8th group not included in the review (Ampe and 
Vandekerckhove, 2005), Dos Remedios et al counted that at least 162 ABPs had been 
identified in the literature by the year 2003 (Dos Remedios et al, 2003). The sheer amount 
and diversity of the functions of ABPs allows the formation of complex, yet highly 
dynamic and effective structures needed to fulfill the various cellular requirements. For 




2.1. The myotilin/myopalladin/palladin protein family 
 
Myotilin, myopalladin and palladin are recently characterized actin-cytoskeleton-
associated proteins, which due to their structural homology are considered to form a novel 
protein family (Otey et al., 2005). They all seem to have an important role in the 






Figure 3. A schematic domain structure illustration of the myotilin/myopalladin/palladin 
protein family members. Only the three major palladin isoforms are included (see section 




The first characterized member of the protein family was myotilin. It was identified in 
a yeast two-hybrid screen in which α-actinin was used as bait (Salmikangas et al., 1999). 
The myotilin cDNA encodes a 498 amino-acid protein composed of a serine-rich amino-
terminus followed by two carboxy-terminal IgC2 domains. The IgC2 domains are most 
homologous to palladin and myopalladin (Otey et al., 2005). In adult humans and mice 
myotilin is expressed mainly in skeletal muscle; lower expression levels are detected in 
heart and peripheral nerves (Mologni et al., 2001; Salmikangas et al., 1999). Myotilin 
plays a role in the late stages of myofibrillogenesis, and when it is overexpressed 
prematurely in myoblasts it prevents normal sarcomere assembly. In the differentiated 
muscle cells myotilin localizes to the Z-disc where it probably provides structural stability 
to the sarcomere by several interactions with other Z-disc proteins. So far myotilin has 
been shown to interact with at least 7 proteins: α-actinin, filamin C, actin, FATZ, ZASP, 











2005;Witt et al., 2005) (Von Nandelstadh, P. 2006 ASCB annual meeting B191; Suila, H. 
2006 ASCB annual meeting B190). 
The interaction between α-actinin and myotilin is mediated by the C-terminal EF hand 
domains 3 and 4 of α-actinin and a short amino-terminal segment of myotilin located 
between amino-acids 79-125. The interaction with filamin C links the sarcomere laterally 
to the sarcolemma at the costamere, since filamins can also interact with adhesion protein 
integrins. Filamins also cross-link actin filaments, and thus the interaction with myotilin 
can enhance the stability of the sarcomere structure (van der Ven et al., 2000). 
Myotilin binds directly to F-actin and bundles actin filaments (Salmikangas et al., 
2003). The binding is mediated by the second Ig domain together with a short C-terminal 
sequence (von Nandelstadh et al., 2005). Furthermore, both the Ig domains and short 
flanking regions within the amino- and carboxy-terminus are needed for actin-bundling 
activity, indicating that the mere actin-binding sequence is insufficient for the actin-
regulating activity. The bundling may also be enhanced by homo-dimerization of myotilin 
(Salmikangas et al., 2003). The interaction with FATZ links myotilin also indirectly to 
costameres, since FATZ can also interact with filamins (Gontier et al., 2005). MuRF, on 
the other hand, is involved in transcriptional regulation initiated by mechanical load. The 
actual role of the interaction with myotilin, however, is still mostly unclear, but it may 
involve ubiqutination of myotilin, as MuRF is also a known ubiquitin ligase (Witt et al., 
2005). The interactions with ZASP and telethonin are also interesting but still need to be 
further characterized.  
Probably the most interesting charateristic of myotilin was revealed at the same time as 
its genetic locus was identified. The myotilin gene is located in chromosome 5q31 which 
also contained an unidentified autosomal dominant limb-girdle muscular dystrophy gene 
(Salmikangas et al., 1999). Subsequently, mutations in the myotilin gene were identified 
as the cause of limb-girdle muscular dystrophy 1A (LGMD1A) (Hauser et al., 2000) and 
later of another myopathy called myofibrillar myopathy (MFM, a.k.a. desmin storage 
disease) (Selcen and Engel, 2004). These diseases have a rather mild phenotype; the 
affected persons manifest with proximal muscle weakness of the extremities, usually later 
in adulthood. MFM patients may also have related cardiomyopathy and peripheral 
neuropathy, fitting well with the above-mentioned adult expression pattern of the myotilin 
gene. The microscopic findings in both of the disorders include Z-disc streaming and 
intracellular aggregates of fibrillar material originating from thin (actin) filaments. The 
causative mutations lead to single amino-acid substitutions, all of which have so far been 
located in the amino-terminal serine-rich part of myotilin. The exact mechanism of how 
these mutations lead to a disease phenotype remains unknown, but they nevertheless seem 
to have a dominant negative effect on the protein function. This assumption is supported 
by the fact that while myotilin knock-out mice lack an obvious phenotype and seem to 
have normal muscle function, a transgenic mouse strain expressing a mutated form of 
myotilin (T57I) recapitulates the disease phenotype (Garvey et al., 2006; Moza et al., 
2007). These mice develop progressive myofibrillar pathology that includes Z-disc 
streaming, myofibrillar vacuolization and myofibrillar aggregation, and progresses with 
age. The mutations do not seem to have any effect on the interaction of myotilin with 






signaling/function of the protein via impaired phosphorylation, since the serine residues 
replaced by mutations are potential phosphorylation sites. 
2.1.2. Myopalladin 
 
Like myotilin, myopalladin was first identified in a yeast two-hybrid screen, in which 
nebulin was used as bait. Myopalladin is a 145-kD protein which has five IgC2 domains 
highly homologous to those of palladin and myotilin (Bang et al., 2001). However, it lacks 
the serine-rich part unique to myotilin and the amino-terminal proline-rich region of 
palladin. Like myotilin, myopalladin is mainly expressed in skeletal and cardiac muscle 
where it also localizes to the Z-disc. It interacts with the SH3 domains of nebulin and 
nebulette, proteins which are thought to play a role in sarcomere assembly (Bang et al., 
2001). Although myopalladin doesn’t have a conventional SH3 ligand PXXP sequence, it 
was shown to bind with micromolar affinity to nebulin SH3 (Ma and Wang, 2002). A 
similar segment in palladin 4Ig isoform was later shown to bind to the LASP-1 SH3 
domain which is highly similar to nebulin (Rachlin and Otey, 2006). Like other members 
of the palladin/myotilin/myopalladin family, myopalladin also binds to α-actinin EF hand 
domains, suggesting that they all may have a somewhat similar role in Z-disc assembly 
(Bang et al., 2001).  
The amino-terminal part of myopalladin binds to the cardiac ankyrin repeat protein 
(CARP), a nuclear protein involved in the control of muscle gene expression. The CARP 
protein family also includes Ankrd2 (a.k.a. Arpp) and diabetes-related ankyrin repeat 
protein DARP. These proteins are possibly involved in relaying signals from the 
cytoskeleton/sarcomere to the nucleus (Kojic et al., 2004; Miller et al., 2003). 
2.1.3. Palladin 
2.1.3.1. Characterization 
Palladin is the third member of the myotilin/myopalladin/palladin family and the main 
subject of this dissertation. Palladin was characterized independently by three groups, one 
group cloned the mouse palladin gene and the other two focused on human palladin. 
Mouse palladin was identified in Carol Otey’s laboratory by the use of an uncharacterized 
monoclonal antibody called C10 (Parast and Otey, 2000). This antibody stained focal 
adhesions and stress-fiber-dense regions, resembling the staining pattern observed for α-
actinin. Futher studies demonstrated that the antibody did not recognize α-actinin, but 
rather a new 90-92 kDa cytoskeletal protein which was named palladin after an Italian 






antibody screen of a phage expression library and data-mining of the mouse sequence 
databases. 
     Human palladin was identified in 2000 by Liu et al., who described a series of 
novel genes up-regulated by all-trans retinoic acid (ATRA) in the NB4 cell line. One of 
them, Rig-K (Retinoic-acid-induced gene-K), was the human homolog of palladin (Liu et 
al., 2000). Almost simultaneously, Mykkänen et al. identified human palladin in a yeast-
two-hybrid screen using a part of the ERM family protein ezrin as bait.  
2.1.3.2. Genomic structure 
Beyond this dissertation, most of the published studies deal with mouse palladin, with 
only a few exceptions so far. The genomic structure of palladin is very complex, and is 
best characterized in mouse – therefore used here as the reference (Otey et al., 2005; 
Rachlin and Otey, 2006). The murine palladin gene is located in chromosome 8 (human 
palladin is located in 4q32.2), spanning 400kb and consisting of at least 24 exons. Human 
palladin has a very similar exon structure. The size of the gene and its structure with at 
least three different promoter regions allows for a very complex transcription process 
resulting in at least 9-10 different products. At the protein level the most common 
products/isoforms have molecular weights of 200, 140 and 90-92kDa. They can also be 
logically named according to their molecular structure, that is, the number of the IgC2 
type domains. The largest 200kDa isoform has two amino-terminal and three carboxy-
terminal IgC2 domains, and is thus called the 5Ig isoform. The 140kDa variant has four 
domains, one amino-terminal domain and three carboxy-terminal domains, and is named 
4Ig isoform. The smallest, and most common, 90-92kDa isoform has only three carboxy-
terminal domains and is therefore called the 3Ig isoform. Located between the second and 
third Ig domains of the 5Ig isoform is a proline-rich sequence that is also contained in the 
4Ig isoform and partly in the amino-terminus of the 3Ig isoform. This sequence contains 
ligands for VASP family member proteins, profilin and SH3 domains. At least in humans, 
additional isoforms exist, which lack the entire proline-rich sequence, but their exact 
identities and sequences are still not known (Rönty, M., unpublished observation). 
2.1.3.3. Interactions  
Besides structural differences, the palladin isoforms have different expression patterns 
and, most likely, partly different interaction partners. The most common 3Ig isoform is 
ubiquitously expressed, at least in developing rodent tissues (Parast and Otey, 2000). The 
140kDa 4Ig isoform seems to be more restricted in its expression, and highest levels of 
this isoform are detected in smooth muscle (Rachlin and Otey, 2006). The largest 5Ig 
isoform seems to be mainly expressed in heart where it may, due to its high sequence 
homology, have functions similar to those of myopalladin (Rachlin and Otey, 2006).  
Several binding partners for mouse palladin have been described so far (summarized in 






section below) (Parast and Otey, 2000; Ronty et al., 2004).  The second identified partner 
was Vasodilator-Stimulated Phosphoprotein (VASP). The VASP family proteins contain a 
specific motif called the EVH1 domain which binds directly to a consensus sequence, 
(D/E)-FPPPP-X(D/E)(D/E), and plays an essential role in targeting these proteins to focal 
adhesions (Krause et al., 2003). Palladin 4Ig isoform contains two and the 3Ig isoform one 
conserved FPPPP sequence(s), and thus palladin was a good candidate for a VASP 
interactor. This was verified by several methods including immunoprecipitation, blot 
overlay and co-localization studies. The proteins were shown to co-localize partially in the 
focal adhesions and stress-fiber-dense regions (Boukhelifa et al., 2004). VASP proteins 
are involved in the regulation of actin assembly and bind directly to both G and F actin 
(Krause et al., 2003). At the lamellipodia, VASP regulates cell motility but its role in 
stress fibers is mostly unknown. It is possible that VASP promotes actin polymerization in 
dense regions, and palladin targets it to these specific sites, but the precise function of the 
interaction remains to be seen. 
The proline-rich sequences found in palladin can also bind profilin (Boukhelifa et al., 
2006), which is a small actin-binding protein that forms a 1 : 1 complex with monomeric 
actin. Profilin promotes the formation of ATP-actin and interacts with the fast-
polymerizing (+)-ends of actin filaments, targeting actin sub-units for growing filaments 
(Korenbaum et al., 1998). Profilin binds also to polyphosphoinositide lipids, the ARP2/3 
complex, members of the VASP, WASP (Wiskott-Aldrich Syndrome Protein) and formin 
families of proteins, all involved in actin dynamics (Witke, 2004). Since palladin also 
plays an important role in the regulation of the actin cytoskeleton, its interaction with 
profilin is likely to have a similar function as with other profilin-binding proteins.Palladin 
also interacts with integrin αvβ5 at the focal adhesions and probably links it to the 
cytoskeleton, but this interaction has not been well characterized (Lai et al., 2006). 
One of the most interesting interactions of palladin is with Lasp-1 (Rachlin and Otey, 
2006). Lasp-1 is an actin-associated protein that contains several conserved domains 
functioning as protein-interaction sites: an amino-terminal LIM domain, followed by an 
actin-binding nebulin repeat domain and a carboxy-terminal SH3 domain (Schreiber et al., 
1998). Lasp-1 binds directly to actin and localizes (together with palladin) in actin-rich 
structures, including focal adhesions and lamellipodia (Chew et al., 2002). The SH3 
domain of Lasp-1 is 80% identical and 86% conserved to that of nebulin, a previously 
characterized binding partner for myopalladin (Bang et al., 2001; Li et al., 2004). 
Moreover, palladin 4Ig isoform contains a myopalladin homologous proline triplet which 
in myopalladin mediates its interaction to nebulin. These facts led Rachlin et al. to test 
whether LASP-1 would bind to palladin 4Ig, and this turned out to be the case. The 
interaction could be shown with several methods including yeast-two-hybrid, GST-
pulldown and co-localization (Rachlin and Otey, 2006). Since the part mediating the 
binding to LASP-1 is not included in the 3Ig isoform sequence, and the expression of the 
5Ig isoform is mostly limited to heart, the interaction seems to be a rather unique feature 
of the 4Ig isoform. It also seems to have a distinct overexpression phenotype, compared to 
the 3Ig isoform: compact star-like actin arrays vs. robust actin-cables, respectively. 
Together, these findings suggest that the different palladin isoforms may also have 






again, remains unknown, but LASP-1 has been implicated to play a role in cytoskeletal 
reorganization in several cell types and localizations. It is overexpressed in some breast 
carcinomas, and possibly plays a role in metastasis through its regulation of cell migration 
(Grunewald et al., 2006). It also localizes to motile growth cones of cultured neurons and 
is involved in chemotaxis (Phillips et al., 2004). 
Eps8 was recently identified as a palladin-interacting protein (Goicoechea et al., 2006). 
Eps8 is a cytoskeletal protein that links growth factor stimulation to actin dynamics and 
participates in the transduction of signals from Ras to Rac (Offenhauser et al., 2004; Scita 
et al., 1999). It binds to several proteins, such as F-actin, EGFR and IRSp53 (Disanza et 
al., 2006; Funato et al., 2004). Eps8 acts as an actin-filament barbed-end capping protein 
and it localizes to membrane ruffles and podosomes (Disanza et al., 2004). Palladin was  
shown to localize both to the PDGF-induced membrane ruffles and phorbol ester-induced 
podosomes in A7r5 cells, together with Eps8. The knock-down of palladin with a siRNA 
resulted in a decrease in Rac activity (possibly via the Eps8 interaction) and also prevented 
the formation of podosomes (Goicoechea et al., 2006). These actin-based membrane 
protrusions have been detetcted in several cell lines, both benign and malignant, and are 
thought to play a role in adhesion and particularly in invasion (Linder and Aepfelbacher, 
2003). Recently, Eps8 expression was shown to be increased in pancreatic cancer (Welsch 
et al., 2007). This is particularly interesting since a palladin mutation has been suggested 
to be one of the causes of familial pancreatic cancer (Pogue-Geile et al., 2006). 
Recently Jin et al (2007) identified palladin as a Lipoma-preferred partner (LPP) 
interacting protein. LPP is a LIM domain family protein that localizes in focal adhesions. 
The palladin-interacting region of LPP was mapped, and both LPP and palladin were 
shown to enhance cell migration and spreading. In FAK-/- cells the expression of LPP and 
palladin was down-regulated, but could be restored by the expression of paired-related 
homeobox gene-1 protein. Also Angiotensin II enhanced expression of both proteins (Jin 
et al., 2007).  
2.1.3.4. Disease associations 
Like myotilin, palladin mutations have been shown to have disease linkages. Probably 
due to their wider expression in tissues, palladin mutations have been shown to play a part 
in such diverse disease states as acute myocardial infarction and familial pancreatic 
cancer. However, unlike myotilin, the described palladin mutations are not concentrated at 
any particular site in the gene. In fact, the SNP suggested to be associated with AMI is not 
in the coding region but is located in the intronic sequence. In one study this SNP lead to 
an increased risk of myocardial infarction (odds ratio OR 1.40, for carriers of two vs. zero 
risk alleles) via an unknown mechanism (Shiffman et al., 2005). In a recent study by 
Home et al (2007) this association, however, could not be validated.  
The other association is even more intriguing. Already in 1995, a large family in which 
pancreatic cancer was inherited in an autosomal dominant fashion was described (Evans et 
al., 1995). Diabetes and exocrine insufficiency were shown to precede pancreatic cancer in 






4q32-34 (Eberle et al., 2002) and finally a mutation in the palladin gene was tracked in all 
the affected family members, while it was absent in the non-affected members (Pogue-
Geile et al., 2006). The mutation causes a proline (hydrophobic) to serine (hydrophilic) 
amino acid change (P239S). Palladin RNA was found to be overexpressed in the 
precancerous dysplastic tissue. The discovered mutation was also shown to have a 
phenotypic effect when a mutated form of the protein was expressed in cultured cells: the 
cells displayed abnormal actin bundle assembly and increased migration. However, the 
study did not answer the question whether this mutation is actually involved in the 
transformation of the cells and, if so, what is the mechanism. In fact, besides the simple 
migration assay and the over-expression phenotype, no function was shown for the 
mutation. These findings prompted other investigators to test whether this mutation could 
be the causative factor for other pedigrees with similar traits. To date, at least three 
independent materials have been screened for this particular mutation, but they have 
turned out negative (Salaria et al., 2007; Slater et al., 2007; Zogopoulous et al., 2007). In 
fact, even the methods used in the primary report were questioned in a recent study. It was 
shown that palladin is not overexpressed in most pancreatic cancer cells, but instead in the 
desmoplastic stroma (note: the stroma also harbours SMA-positive myofibroblasts). The 
authors thus concluded that overexpression of palladin is not likely to be responsible for 
the invasive and migratory capacity of pancreatic cancer cells (Salaria et al., 2007). 
Obviously further studies are needed to settle the issue. 
A suggestive linkage at chromosome 4q32 in pre-eclampsia was recently identified, 
but so far the responsible gene has not been mapped. Interestingly, very recently 
Jarvenpaa et al. (2007) reported from an independent material that palladin is down-
regulated in pre-eclampsia. Together these studies suggest that palladin might play a role 
in the pathogenesis of pre-eclampsia, but this result still needs to be verified. 
2.1.3.5. Palladin in the nervous system 
The role of palladin in tissues has been studied mostly in the rodent central nervous 
system. Otey et al. first showed that palladin is widely, though not uniformly, expressed in 
rat brain and spinal cord. The highest expression was detected in the olfactory bulb, 
cerebral and cerebellar cortex, hippocampus, amygdala, superior colliculus, and 
superficial laminae of the spinal dorsal horn. In these locations palladin co-localized at the 
sub-cellular level with synaptophysin, a presynaptic vesicle-associated protein. More 
precisely, palladin was shown to be selectively expressed in excitatory synapses (Hwang 
et al., 2001). 
In cultured neuronal cells, palladin was shown to localize to the developing axons but 
not to the dendrites. Palladin was highy concentrated in the axonal growth cone, a place 
where constant and rapid re-organization of the cytoskeleton takes place. When palladin 
expression was down-regulated by antisense technology, the neurites didn’t develop 
normally, suggesting a role for palladin in the axonal extension (Boukhelifa et al., 2001). 
Palladin is highly expressed, not only in neurons, but also in astrocytes. These cells 






cultures were wounded, thus simulating an injury, they showed rapid up-regulation of 
palladin in the cells at the wound edge. Simultaneously, the morphology of the cells 
changed from the inactive stellate to the active polygonal shape. In vivo palladin was 
similarly up-regulated at the edges of an experimantal stab wound to the cerebral cortex of 
rats (Boukhelifa et al., 2003). These results suggest that the up-regulation of palladin 
might be an important step in the acquisition of the reactive astrocyte morphology and 
thus formation of the glial scar.The results obtained with palladin knock-out mice (see 
next section) also suggest that palladin plays an important role in the nervous system (Luo 
et al., 2005). 
2.1.3.6. Genetically modified palladin-negative (knock-out) mice 
In 2005, the first construction of a genetically modified palladin-negative (knock-out) 
mouse strain was reported (Luo et al., 2005). The investigators showed that the genetic 
inactivation of palladin leads to embryonic lethality due to defects of cranial neural tube 
closure and herniation of liver and intestine. The palladin−/− mouse embryos had neural 
tube closure defects and died already at E15.5 (Luo et al., 2005). Palladin was shown to be 
expressed in the cranial neural folds of the wild-type embryos. Also, an idependent study 
focusing on chicken neural crest development showed a similar expression pattern 
(Gammill and Bronner-Fraser, 2002). Since the closure of the neural tube requires active 
migration of the cells, it is likely that the resulting closure defect in palladin-/- embryos 
was caused by disturbed cell migration. This notion was further supported by the findings 
obtained in vitro with palladin-/- murine embryonic fibroblasts (MEF). The cells displayed 
defects in the formation of stress fibers, lamellipodia and focal adhesions, adhesion to the 
ECM, and migration (Luo et al., 2005). G- to F-actin ration was elevated and β1-integrin 
was down-regulated, reflecting the disorganization of the cytoskeleton and diminished 
adhesion (Liu et al., 2007b).Furthermore, palladin-/- embryos have defects in 
erythropoiesis due to the abnormal function of macrophages, and a consequently 
compromised erythropoietic microenvironment (Liu et al., 2007a). 
2.2. α-actinin 
 
The first characterized interaction partner of palladin was α-actinin (Parast and Otey, 
2000). In humans, there are four α-actinin genes encoding proteins, α-actinin1-4. α-
actinins 2 and 3 are restricted to striated muscle, where they localize to the Z-disc and 
sarcolemma. Nonmuscle α-actinins 1 and 4 are located in focal contacts, cell-cell contacts, 
stress-fiber-dense regions and cortical actin networks. All the α-actinins have a similar 
structure: an amino-terminal actin-binding domain (ABD) composed of two calponin 
homology domains followed by a central rod-domain consisting of four spectrin-like 
repeats, and a carboxy-terminus consisting of a calmodulin-like (CaM) domain with two 






links actin fibers. Besides its function in stabilizing the actin bundles α-actinin also 
connects the cytoskeleton to transmembrane proteins in both cell-cell and cell-matrix 
contacts. It regulates both directly and indirectly different receptor activities and links the 
cytoskeleton to signaling pathways (reviewed in Vallenius(2004); academic dissertation) 
(Otey and Carpen, 2004). 
α-actinin has a plethora of binding partners both in muscle and non-muscle cells; so far 
>40 proteins have been identified as interactors (reviewed in Klaavuniemi(2006); 
academic dissertation, Vallenius(2004); academic dissertation and Otey and Carpen, 
2004). Since the list of binding partners is too elaborate to be discussed in detail here, only 
a few examples of each of the specific cell types and sub-cellular compartments are 
mentioned.In non-muscle cell adhesion sites, such as, focal adhesions, hemidesmosomes 
and neuronal synpases, α-actinin interacts with several transmembrane proteins, linking 
cells either to extracellular matrix or to neighbouring cells. In focal adhesions it binds to 
the ß1 integrin subunit that anchors the cytoplasmic actin filaments to the plasma 
membrane (Otey et al., 1990). Another plasma-membrane-associated interactor is 
syndecan-4, a transmembrane proteoglycan, which also binds to the extracellular matrix 
(Greene et al., 2003). Intercellular adhesion molecules (ICAMs) and adherent junction 
protein ADIP and α-catenin bind also to α-actinin. One of the most important binding 
partners on the cytoplasmic part of the focal adhesions is vinculin, one of the most studied 
focal adhesion proteins. The role of α-actinin in the adhesions is to provide stability for 
theses structures and thus maintain cell shape. It can also enhance the adhesion by 
clustering transmembrane proteins to these sites, as is known for ICAM-2 (Carpen et al., 
1992). α-actinin also participates in the signaling cascades which converge in the 
adhesions. This is particularly highlighted by the fact that the integrin-activated tyrosine 
kinase, Focal Adhesion Kinase (pp125FAK) phosphorylates α-actinin and reduces its 
affinity towards actin (Izaguirre et al., 2001). 
  The major function of α-actinin in actin stress fibers appears to be its cross-linking of 
actin filaments. It localizes to specific structures called dense regions, which are 
considered to be the non-muscle equivalent of the sarcomeric Z-discs (Small and Gimona, 
1998). In this localization α-actinin also associates with several proteins, such as zyxin, 
CLP-36 and palladin (Crawford et al., 1992; Parast and Otey, 2000; Vallenius et al., 
2000). Although the precise function of these α-actinin-associated molecules in the stress 
fibers is mostly unknown, they possibly facilitate the actin cross-linking role or α-actinin 
and regulate stress fiber dynamics. In addition to this structural role, α-actinin can 
participate in signaling in the stress fibers simply by regulating the distribution of proteins 
within the cell. This is true at least for zyxin and the CLP-36 -associated kinase Clik1, 
which are known to shuttle between the cytoplasm and nucleus (Reinhard et al., 1999; 
Vallenius and Makela, 2002). 
In the muscle cells α-actinin localizes to the sarcomeric Z-disc and the costameres, 
specific structures linking the sarcomere to the extracellular matrix via adhesion proteins. 
The Z-disc is a highly organized structure within the muscle cell where the thin actin 
filaments of opposing sarcomeres are crosslinked together. The structure of the Z-disc 
contributes to the force transmission between sarcomeres and is involved in the regulation 






point of several signaling cascades within the muscle cells (reviewed in Salmikangas 
(2001); academic dissertation and Klaavuniemi(2006); academic dissertation, Frank et al., 
2006). α-actinin is probably the most important component of the Z-disc and binds most of 
the known Z-disc proteins, including ALP, ZASP, FATZ, myopalladin, palladin, ArgBP2 
and titin (Klaavuniemi(2006); academic dissertation). 
Studies on Drosophila mutants have shown that α-actinin plays a crucial role in 
maintaining the sarcomeric integrity and muscle function. α-actinin-deficient embryos die 
early at the larval stage due to degeneration of myofibrils characterized by the disruption 
of Z-disks (Fyrberg et al., 1998). 
In the costamere, located at the Z-disc/sarcolemmal junction, α-actinin connects the 
contractile apparatus to the extracellular matrix via several interactions to both 
sarcoplasmic and transmembrane proteins, such as vinculin, dystrophin and integrins. 
These interactions enable the force generated by the contraction of the sarcomere to be 
mediated to the extracellular matrix. 
2.3. The ERM (Ezrin/Radixin/Moesin) protein family 
The ERM (ezrin/radixin/moesin) family consists of cytoskeletal proteins that are 
concentrated in actin-rich cell-surface structures where they link the actin cytoskeleton 
with the plasma membrane. They share a homologous amino-terminal domain, referred to 
as FERM (protein 4.1 ERM), followed by an α-helical region and a carboxy-terminal 
domain (Bretscher et al., 2002). ERMs remain in an inactive conformation in the 
cytoplasm through an intramolecular interaction between their amino- and carboxy-
terminal domains. Once they are activated, either by binding to phospholipids or by 
phosphorylation, they are able to  bind to the cytoplasmic part of  transmembrane proteins, 
including CD43, CD44, CD95, ICAM-1, -2, -3, and syndecan-2 (Bretscher et al., 2002). 
ERM family proteins also bind actin and thus provide a link between the cytoskeleton and 
transmembrane proteins in cell-cell and cell-matrix adhesions, similar to α-actinin. They 
localize beneath the plasma membrane in the subcortical actin network, in specialized 
cellular structures such as microvilli and lamellipodia (Bretscher et al., 1997; Bretscher, 
1999; Bretscher et al., 2002). They also maintain cell shape and polarity, and participate in 
cell motility and membrane trafficking. Besides this structural role, they are directly linked 
to signaling pathways, and can for instance activate members of the rho protein family. 
The neurofibromatosis 2 (NF2) tumour-suppressor protein merlin (a.k.a schwannomin), is 
highly homologous with the ERM proteins and is now considered to be a member of this 
protein family. It has some overlapping functions with other ERMs but also some 










Ezrin was first described to be a cytoskeletal component of the intestinal-brush border 
(Bretscher, 1986; Bretscher et al., 2002). In vivo, it is mainly expressed in epithelium but 
has a wider distribution in cultured cells. Besides adhesion molecules (see above) ezrin 
interacts with signaling proteins of the phosphatidylinostiol-3-kinase (PI3K), protein 
kinase A and Rho pathways (Ivetic and Ridley, 2004). It thus works as a molecular 
scaffold in targeting intracellular signals. Ezrin is also phosphorylated in vivo both on 
serine/threonine by protein kinase C and Rho kinase, and on tyrosine by Src family 
kinases (Autero et al., 2003; Gautreau et al., 2000; Heiska and Carpen, 2005). 
Studies on ezrin knockout mice have shown that, while ezrin is not crucial for the 
formation of brush border microvilli or for the maintenance of epithelial cell polarity, it 
plays a critical role in the lumen formation and expansion during villus morphogenesis 
(Saotome et al., 2004). The up-regulation of ezrin expression has morphogenic effects and 
is associated with tumor metastasis (Curto and McClatchey, 2004; McClatchey, 2003). In 
a mouse model of osteosarcoma, ezrin has been shown to be necessary for metastasis 
(Khanna et al., 2001; Khanna et al., 2004; Wan et al., 2005; Yu et al., 2004). Its 
expression provided a survival advantage for cancer cells that reached the lung, partially 
dependent on the activation of MAPK. These experimental results are supported further by 
the finding that high ezrin expression correlates with poor outcome in pediatric 
osteosarcoma patients (Kim et al., 2007). 
The findings described above suggest that ezrin (and the ERM proteins) plays an 
important role in various cellular processes including adhesion, apoptosis, cell movement 
and tumor metastasis. 
2.4. The ArgBP2 protein family 
 
ArgBP2 forms, together with Vinexin and CAP/Ponsin, an adaptor protein family 
(Kioka et al., 2002). From the structural point of view, all the family members share a 
SoHo (sorbin homology domain) in their amino-terminal part, followed by three carboxy-
terminal SH3 domains. They also contain several proline-rich sequences that can serve as 
ligands for SH3 domains. The sequence identity within the domains is high among the 
family members, ranging from 34% (SoHo domains) to 73% (SH3 domains). Since the 
SH3 domains are known to have a broad specificity towards their ligands, it is not 
surprising that all the ArgBP2 family proteins have several binding partners, some of 
which are shared between the members (e.g. vinculin) (Kioka et al., 2002). Specific 
binding partners have also been identified, including Sos and flotillin for Vinexin; and 
Grb4, ataxin 7, c-Cbl, the insulin receptor and Paxillin for CAP/Ponsin (Kioka et al., 
2002). Besides their structural similarities, the proteins share other properties as well. 
They all have a ubiquitous tissue distribution but show the highest expression in heart. 






adhesions, and CAP/Ponsin and ArgBP2 also localize partly to the nucleus. However, 
unlike its relatives, ArgBP2 also localizes to the stress-fiber-dense regions in non-muscle 
cells and in sarcomeric Z-discs in cardiomyocytes (Kioka et al., 2002).  
 
ArgBP2 was initially isolated as a binding partner for the non-receptor tyrosine kinase  
c-Arg (c-Abl2) in a yeast-two-hybrid screen (Wang et al., 1997). It co-localizes with Abl 
in cells, and is phosphorylated on tyrosine by Abl both in vitro and in vivo (Wang et al., 
1997). Although the physiological function of the Abl family kinases is not entirely clear, 
they do have several connections to the cytoskeleton: both Abl and Arg can directly bind 
actin and they have several cytoskeletal targets, such as p130CAS and cortactin 
(Hernandez et al., 2004; Lanier and Gertler, 2000; Wang et al., 2001). ArgBP2 can also 
regulate indirectly the activity of Abl by linking it to the ubiquitin ligase Cbl. 
Phosphorylation of Cbl and ArgBP2 by Abl results in the stabilization of their 
interactions, thus facilitating Cbl-induced ubiquitination and subsequent degradation of 
Abl and ArgBP2 (Soubeyran et al., 2003). ArgBP2 links also to cell survival/apoptosis via 
its interactions with Akt and PAK1 (Yuan et al., 2005). ArgBP2 binds to both of these 
kinases and is phosphorylated on serine/threonine by Akt. This phosphorylation induces 
PAK1 activation which subsequently prevents DNA-damage-induced apoptosis (Yuan et 
al., 2005). Yet another ArgBP2 interacting kinase is Pyk2, whose activation, among other 
things, has been linked to dilatation-induced cardiac remodelling (Haglund et al., 2004). 
Since it has no enzymatic activity itself, ArgBP2 probably functions as a molecular 
adaptor which via several potentially simultaneous protein-protein interactions brings 
together effectors and their targets. This is also probably true in cardiomyocytes in which 
several signalling cascades have been shown to converge at the Z-disc (Frank et al., 2006).  
In neuronal tissue, ArgBP2 is expressed as a specific isoform, nArgBP2, which 
contains a 606 amino-acid zinc-finger motif insertion. It localizes to the postsynaptic 
density where it interacts with SAPAP (SAP90/PSD95-associated protein) and afadin-1 
(Kawabe et al., 1999). nArgBP2 also interacts with several cytoskeletal proteins, including  
spectrin, dynamin, synaptojanin, and WAVE isoforms, as well as WAVE regulatory 
proteins (Cestra et al., 2005). At least two of the ArgBP2/nArgBP2 binding partners, 
synaptojanin 2B and WAVE2, undergo ubiquitination and Abl-dependent tyrosine 
phosphorylation. The knockdown of nArgBP2 with a specific siRNA induces 
redistribution of focal adhesion proteins and an increase in peripheral actin ruffles in 
astrocytes (Cestra et al., 2005). The multitude and nature of nArgBP2 interactions 
suggests that, although it might have additional functions mediated by the zinc-finger 









SPIN90 (SH3 Protein Interacting with Nck, 90 kDa) cDNA was first isolated from a 
yeast two-hybrid screen where Nck Src homology 3 (SH3) domains were used as bait 
(Lim et al., 2001). Later, an independent group characterized the same protein which they 
named diaphanous-interacting protein (DIP) (Satoh and Tominaga, 2001). For the sake of 
simplicity, the results dealing with DIP are discussed here under the name SPIN90. 
SPIN90 is a 722 residue protein, containing an SH3 domain, proline-rich motifs, a 
serine/threonine-rich region, and a long C-terminal hydrophobic region. The amino acid 
sequence of the SH3 domain has the highest homology with Src family kinases (Src, 
Fyn,Yes). It shows high sequence similarity to VIP54 and WISH (Lim et al., 2001). 
SPIN90 is ubiquitously expressed in human tissues; the highest expression is seen in heart, 
brain, and skeletal muscle. It localizes to the sarcomere Z-discs in cardiomyocytes (Lim et 
al., 2001), to filopodia and dendritic spines in neuronal cells, and to actin-based structures 
such as membrane ruffles in non-muscle cells (Kim et al., 2006; Kim et al., 2005). It plays 
a role in myofibril and sarcomere assembly, since both depletion and over-expression of 
SPIN90 in cardiomyocytes results in sarcomere disruption (Lim et al., 2001) (E.Ehler, 
unpublished observation). SPIN90 probably acts as a scaffolding protein, since it interacts 
with several actin-regulating proteins including Nck, N-WASP, βPIX, the Arp2/3 
complex, dynamin, PSD-95 and mDia (Kim et al., 2006; Kim et al., 2005; Lee et al., 
2006).  
During cell adhesion and PDGF stimulation, SPIN90 is phosphorylated by ERK1 and 
subsequently forms a complex with betaPIX and WASP. Furthermore, this complex 
interacts with Nck at focal adhesions. These interactions probably play a role in 
establishing stable cell adhesion and can be dynamically modulated by SPIN90 
phosphorylation by ERK1 (Lim et al., 2003). 
Several studies have suggested that SPIN90 is involved in regulating the cortical actin 
cytoskeleton during lamellipodia formation and cell movement. When cells are stimulated 
by growth factors such as EGF and PDGF, they rapidly form membrane protrusions 
(called lamellipodia) at the leading edge preceding cell movement. Upon such stimulation 
SPIN90 re-localizes from its normal rather diffuse cytoplasmic position to the cortical 
actin network. There SPIN90 binds to several actin-associated and signaling proteins, such 
as, p190RhoGAP, Vav2, the Arp2/3 complex, palladin and actin itself (Eisenmann et al., 
2007; Kim et al., 2006; Meng et al., 2004). SPIN90 is phosphorylated by Src and 
subsequenlty mediates the phosphorylation of p190RhoGAP and Vav2. This leads to 
inactivation of Rho and activation of Rac, which in turn results in a loss of actin stress 
fibers and formation of lamellipodia. Binding of SPIN90 to the Arp2/3 complex  mediates 
its activation and and formation of branched actin networks at the leading edge of cells. 







In the neuronal cells SPIN90 is involved in diverse processes, such as synaptic vesicle 
endocytosis and dendritic spinogenesis and synaptogenesis. SPIN90 is expressed in both 
pre- and postsynaptic compartments (Kim et al., 2005). In the presynaptic position it 
interacts which dynamin I, a membrane-associated protein involved in endocytosis. Both 
overexpression and siRNA-mediated knock-down of SPIN90 interfered with synaptic 
vesicle endocytosis, possibly by modulating the interaction of dynamin I with other 
endocytic proteins (Kim et al., 2005). 
On the postsynaptic side, SPIN90 interacts with PSD-95 and is involved in dendritic 
spinogenesis by modulating the actin dynamics of the spines (Lee et al., 2006). When 
SPIN90 is overexpressed in neuronal cells it increases the number and size of the dendritic 
spines and, vice versa, knock-down of SPIN90 reduces the density of the spines. A 
neuronal isoform of ArgBP2, i.e. nArgBP2, has been also shown to localize to the 
postsynaptic density where it interacts with SAPAP (SAP90/PSD-95-associated protein) 
(Kawabe et al., 1999). This raises the possibility that ArgBP2 and SPIN90 could be 
involved in the same processes, particularly since they both associate with palladin. 
3. Regulation of the actin cytoskeleton 
The actin cytoskeleton is involved in several cellular processes including regulation of 
cell shape and polarity, motility and adhesion. In order to perform all these functions, the 
cytoskeleton must be able to form stable and durable structures but also, at the same time, 
be highly dynamic and flexible. This duality is achieved by formation of divergent 
complexes with actin-binding proteins (ABP) resulting in actin-based structures with 
different physical and functional properties. Various cellular cues regulate the actin 
cytoskeleton via signaling proteins and small molecules which mainly act by either 
activating or inhibiting ABPs. For example, during cell migration, actin filaments are 
assembled into a complex network at the protruding leading edge, while they must be 
disassembled simultaneously in the cell body to facilitate movement.  
Several signaling pathways are involved in actin cytoskeleton regulation; one of the 
most extensivley studied is the Rho family of small GTPases. This family includes RhoA, 
Rac1 and Cdc42, each of which have different functions. Activation of Cdc42 and Rac1 
control the formation of filopodia and lamellipodia, respectively. RhoA, on the other hand, 
induces the formation of stress fibers. These proteins cycle between an active GTP form 
and an inactive GDP form. The activation status is regulated by guanine nucleotide 
exchange factors (GEF) that promote GDP-GTP exchange, GTPase activating proteins 
(GAP) that stimulate inactivation, and Rho guanine nucleotide dissociation inhibitors 
(Rho-GDI) that stabilize the inactive protein form. 
RhoA can be activated by several pathways which include both chemical mediators 
(LPA) and physical stress (shear stress). Once activated, RhoA induces stress fiber and 
focal adhesion formation by interacting with several effector proteins including Rho-
Kinase (ROCK), PI 5-kinase and Formins (Maekawa et al., 1999; Matsui et al., 1996). 
ROCK subsequently activates LIM-kinase (LIMK) and phosphorylates Myosin Light 






cofilin (an actin filament depolymerizing factor) leading to accumulation of actin stress 
fibers (Ohashi et al., 2000). The phosphorylation of MLC also increases the contraction 
and assembly of stress fibers (Kureishi et al., 1997). Although this pathway is indeed quite 
complex and can be regulated at each step by additional factors, it is still very swift and 
efficient. 
Rac1 is active at the leading edge of cells, and its inhibition reduces lamellipodium 
extension. Rac1 targets WAVE and N-WASP also localize in the lamellipodia, where they 
promote actin nucleation by the Arp2/3 complex (Small et al., 2002). Interestingly, 
palladin is also involved in lamellipodia organization by interacting with Eps8 and by 
indirectly regulating Rac activity (Goicoechea et al., 2006). 
Besides the Rho family, actin cytoskeleton is also regulated by both receptor and non-
receptor tyrosine kinases. These include for instance the PDGF receptor (PDGFR) and the 
Src and Abl kinase families. There is considerable cross-talk between these kinase 
cascades, and in fact PDGF mediates its cytoskeletal effects partly via Src, which 
subsequently can activate Abl kinases (Boyle et al., 2007).  
 
3.1. The Src-kinase family 
 
The Src family of tyrosine kinases (SFK) has nine members: Src, Lck, Hck, Fyn, Blk, 
Lyn, Fgr, Yes and Yrk (Brown and Cooper, 1996). The kinases are 52-62 kD proteins, 
which have a similar structure with conserved domain regions called SH (Src homology) 
domains 1-4. The SH4 domain is myristylated and targets the kinases to the cell 
membrane. The SH3 and SH2 domains mediate both intra- and intermolecular interactions 
to proteins affecting catalytic activity and sub-cellular localization; they also link the 
kinases with their targets (Brown and Cooper, 1996). SH3 domains bind to proline-rich 
target sequences which have a PxxP core motif (Kay et al., 2000). SH2 domains, on the 
other hand, bind to phospho-tyrosine residues within longer amino-acid sequences. The 
kinase domain, SH1, displays kinase activity and also binds to substrates. 
As the name implies, Src is the founding member of the Src family protein tyrosine 
kinases. It was originally identified as the transforming protein (v-Src) of the oncogenic 
retrovirus, Rous Sarcoma Virus (RSV) (Brown and Cooper, 1996). v-Src is a mutated and 
thus constantly activated version of the normal cellular protein (c-Src). Because its 
uncontrollable activity can lead to cellular transformation and tumor formation, v-Src is an 
oncogene, whereas c-Src is a proto-oncogene. c-Src is held in an inactive state by an auto-
inhibitory mechanism involving the SH3 and SH2 domains. The SH2 domain binds to a 
phosphorylated inhibitory tyrosine (Y527) near the carboxy-terminus of the protein, thus 
facilitating the binding of the SH3 domain to a polyproline site within a linker region 
between the SH2 and Kinase domains. This leads to a conformational change in the kinase 






mechanisms including integrin engagment and receptor tyrosine kinases, for instance 
PDGFR (platelet-derived growth factor receptor)(Brunton et al., 2004). Activation of Src 
leads to tyrosine phosphorylation of several cytoskeletal/adhesion target proteins including 
vinculin, cortactin, paxillin, ezrin, p130cas, β - and γ -catenin, ZO-1 and connexin 43 
(Brown and Cooper, 1996; Heiska and Carpen, 2005). It also phosphorylates signalling 
proteins such as FAK, Vav, p190rhoGAP and Eps8 (Brown and Cooper, 1996).  
Src activation results in alterations of the cell structure, particularly in the actin 
cytoskeleton and the adhesion networks controlling cell migration. It also transmits signals 
that regulate proliferation and cell survival. The cytoskeletal effects induced by Src 
include disruption of cell-cell adhesions and stress fibers, and formation of membrane 
ruffles and podosomes (Brunton et al., 2004; Frame et al., 2002; Frame, 2004). Podosomes 
are actin-rich membrane protrusions which are involved in both adhesion and invasion 
(Linder and Aepfelbacher, 2003). Interestingly, palladin and a known Src substrate Eps8 
have recently been shown to localize to these structures (Goicoechea et al., 2006). As a 
result of these events, the transformed cells are more motile and thus probably more prone 
to invade tissues and metastasize to remote sites (Frame, 2002). 
4. The myofibroblast 
Myofibroblasts are specialized cells that originate from normal fibroblasts, circulating 
progenitor cells called fibrocytes and epithelial cells through a process termed epithelial-
mesenchymal-transition (EMT) (Hinz et al., 2007). They are found in vivo in both 
physiological and pathological processes (Powell et al., 1999). The main function of 
myofibroblasts is to modulate the extracellular matrix (ECM) by actively secreting 
variable extracellular proteins, such as structural matrix proteins (fibronectin, collagen), 
proteases (Matrix Metallo Proteases, MMP), cytokines (Monocyte Chemotactic Protein -
1) and growth factors (TGF and PDGF) (Tomasek et al., 2002; Tomasek et al., 2002). The 
most studied and therefore the best known function of myofibroblasts is in the formation 
of granulation tissue during dermal wound healing. In granulation tissue, the cells generate 
the contractile force which ensures wound closure. After the wound has healed, 
myofibroblasts normally disappear by apoptosis (Desmouliere et al., 1995). In 
fibrocontractive diseases, such as idiopathic lung fibrosis, glomerulosclerosis and 
contractures, myofibroblasts avoid apoptosis and remain in the tissue. They continue to 
contract actively and to produce the ECM components leading to tissue deformation and 
fibrosis (Desmouliere et al., 2003; Desmouliere et al., 2005). This process represents 
“over-healing” due to repeated bouts of tissue damage followed by continuing 
myofibroblast activation. 
The formation of myofibroblasts from normal fibroblasts, fibrocytes and epithelial 
cells involves a mechanical stimulus to the cells by tension in the ECM, as well as 
chemical stimuli by growth factors and cytokines (Hinz and Gabbiani, 2003a; O'Kane and 
Ferguson, 1997). Under normal physiological condition, fibroblasts reciding in the ECM, 
for example in dermis, do not have cytoplasmic stress fibers. Once an injury, such as a 






by the inflammatory cells activate the cells, leading first to the formation of so-called 
proto-myofibroblasts (Tomasek et al., 2002). These cells differ from normal fibroblasts by 
containing stress fibers composed of cytoplasmic β and γ actins. Upon further maturation 
the cells acquire some smooth muscle characteristics, including neo-expression of actin-
associated proteins and α-smooth muscle actin (α-SMA)(Tomasek et al., 2002). To date, 
α-SMA is considered to be the most reliable marker of the differentiated myofibroblast 
(Darby et al., 1990; Skalli et al., 1986). The proto-myofibroblast/myofibroblast sequence 
also explains the discrepancies between the initial and more recent characterization of 
these cells. Since myofibroblasts were initially studied by electron microscopy, they were 
identified by the the presence of stress fibers and focal ahdesions (fibronexus). Electron 
microscopy cannot, however, distinguish the α-SMA-negative proto-myofibroblasts from 
the fully differentiated α-SMA-positive myofibroblasts. This lead to misinterpretations 
after the charazterization of the α-SMA antibody (so-called α-SMA-negative 
myofibroblasts). Besides expressing α-SMA, myofibroblasts can express other smooth 
muscle proteins including smooth muscle myosin heavy chains, calponin, SM-22α and 
calgizzarin (Malmstrom et al., 2004). Usually they do not attain all the characteristics of 
smooth muscle, for instance, they only rarely express desmin and smoothelin (Tomasek et 
al., 2002). The process of epithelial-to-mesenchymal transition (EMT) has recently 
received much attention. This process has been shown to be an important way of 
producing myofibroblasts at the site of tissue injury, for example in lung fibrosis and 
glomerulosclerosis (Desmouliere et al., 2003; Hinz et al., 2007). In the former, 
differentiated epithelial cells lose their epithelial phenotype (expression of cytokeratin 
isoforms and cell-cell adhesion molecules such as E-cadherin) and start to express 
mesenchymal markers, most importantly vimentin and α-SMA.    
The best characterized chemical mediator of myofibroblast differentiation is 
transforming growth factor-β1 (TGF-β1). TGF-β1 is produced in dermal wounds by 
keratinocytes, leukocytes and fibroblasts, and it is also released by platelets (O'Kane and 
Ferguson, 1997). Inflammatory leukocytes, especially macrophages, are a source of TGF-
β1 also in  lung and hepatic fibrosis. TGF-β1 binds to its receptor at the cell membrane 
leading to receptor autophosphorylation. The active receptor is a serine/threonine kinase 
which subsequently phosphorylates Smad2 and Smad3 members of the SMAD signaling 
pathway. Both Smad 2 and 3 bind to Smad4 and translocate to the nucleus to regulate gene 
transcription together with transcription factors. This pathway can be inhibited by the 
action of Smad7, an endogenous inhibitory member of the Smad family (Massague, 2000). 
TGF-β1 also activates the mitogen-activated protein kinase (MAPK) signaling cascade 
(Leivonen et al., 2002). Most importantly, it activates ERK1/2 (extracellular signal-
regulated kinase) and p38. Both of these proteins are serine/threonine kinases which 
regulate various cellular activities, such as gene expression, differentiation and apoptosis. 
There is also cross-talk between the Smad and MAPK signaling cascades, and MAPKs 









Aims of the study 
 
This study was initiated by Dr. Olli-Matti Mykkänen together with Prof. Olli Carpen. 
They were looking for novel binding partners for the ERM-family protein ezrin and 
identified a novel protein, subsequently named palladin. Characterization of this novel 
protein became the focus of further studies which eventually led to this dissertation. 
The initial aims included: 
1) determination of the structure of the human palladin gene and protein 
2) characterization of the tissue distribution of palladin and its sub-cellular 
localization 
3) characterization of the interaction between palladin and ezrin and the regulation of 
palladin expression during dendritic cell differentiation 
After this preliminary work the subsequent studies aimed to: 
1) characterize the interaction between palladin and α-actinin in detail 
2) identify novel binding partners for palladin 

















The materials and methods are described in detail in the original publications, and only 





Used in study 
Northern blot analysis I 
Cell cultures and transfections I-V 
Polyclonal antibody production I, IV 
Immunofluorescence microscopy I-V 
Immunohistochemistry I, IV 
Production of recombinant DNA constructs I-III 
Yeast two-hybrid analysis 
- library screen 




Protein affinity precipitation I-III, V 
Protein blot overlay  I 
Western blot analysis and immunoblotting I, IV 
Co-immunoprecipitation III, V 
In vitro protein translation II, III, V 
Flow cytometry I 
Production of recombinant proteins I-V 
RNA interference by siRNA  V 
Primary culture of neo-natal rat cardiomyocytes III 
RNA isolation and RT-PCR IV 
Mitochondrial outer membrane (MOM) targeting assay II, III, V 
Recombinant adenovirus transduction IV 












RESULTS AND DISCUSSION 
1. Characterization of human palladin (I) 
1.1. Cloning and sequence analysis of human palladin cDNA  
In order to find novel molecules interacting with ezrin, we performed a yeast two-
hybrid screen with a bait construct containing the α-helical and carboxy-terminal domains 
(amino acids 278-585) of ezrin. With this approach, two identical 899-bp clones encoding 
for the last 254 amino acids of a novel gene product were isolated from a HeLa cell cDNA 
library. Sequence comparisons in the BLAST database identified a 4347-bp cDNA clone 
(accession no. AB023209, protein accession no. KIAA0992), which included the isolated 
sequence. This cDNA was predicted to encode the C-terminal 772 amino acids of a novel 
protein. Because the mouse ortholog was identified during the progress of this work and 
named palladin (Parast and Otey, 2000), we decided to comply with the nomenclature, and 
name also the human protein palladin (the sequences across these species are highly 
homologous, showing ~90% similarity). Since the AB023209 cDNA did not contain an in 
frame stop codon or a Kozak consensus sequence before the first ATG codon, it was 
considered to be a partial cDNA. More recent studies with the mouse palladin gene, 
however, suggested that this cDNA indeed contains the full-length human palladin 3Ig 
isoform sequence and has an additional 5’ part from the 4Ig isoform (Otey et al., 2005; 
Rachlin and Otey, 2006)  
By structural prediction, the identified human palladin cDNA contains three Ig-
domains in the carboxy-terminal part of the molecule. These Ig-domains are most 
homologous to those found in myopalladin and myotilin, two Z-disk-associated 
sarcomeric proteins (~63% and ~49% identity with palladin, respectively). Together these 
three proteins form a new Ig domain protein family. The Ig domains of palladin are also 
homologous to Ig domains Z6-8 present in the Z-disc-associated region of the sarcomeric 
protein titin (31% identity). Part of the amino-terminal region is homologous to myotilin 
(34% identity and 44% similarity for residues 118-327 of palladin and 2-191 of myotilin). 
However, palladin has two polyproline stretches not found in myotilin. 
1.2. Expression pattern of palladin 
Northern blot analysis indicated that palladin is expressed in a wide variety of tissues. 
A strong signal was seen in prostate, testis, ovary, small intestine and colon. A weaker or 
nondetectable signal was present in hematopoietic tissues: thymus, spleen, and peripheral 
blood lymphocytes. The size of the major transcript was ~4.5 kb. Western blot analysis of 
the tissue lysates was performed with polyclonal antibodies raised against a synthetic 17-
mer peptide. The analysis showed strong reactivity in prostate, ovary, and colon, tissues 
positive in mRNA analysis, and in kidney, whereas hematopoietic tissues expressed little 
palladin.  
1.3. Localization of palladin  
The subcellular localization of palladin was studied by immunofluorescence 
microscopy of cultured cells. In HISM (human intestinal smooth muscle), U251mg 
glioblastoma and HeLa cervical squamous carcinoma cells, palladin was detected in the 
stress-fiber-dense regions and to some extent in focal adhesions.  
In transient transfection experiments, a myc-tagged carboxy-terminal palladin construct 
was expressed in HeLa cells and detected with an anti-myc mAb. The transfected protein 
localized along actin microfilaments in a pattern resembling that of the endogenous 
protein. The transfection results confirmed the immunolocalization of the endogenous 
protein and indicated that the Ig-domain-containing carboxy-terminus can be targeted to 
microfilaments. Palladin distribution was also analyzed in frozen sections of a human 
stomach carcinoma specimen. Strong staining was observed in the smooth muscle layer of 
the stomach, and the serosal vessel walls (tunica media). Reactivity was also detected in 




Figure 4. Palladin localizes to different actin-based cellular structures. A) U251 cells 
stained with the palladin 3Ig antibody display the typical pattern of the stress-fiber-dense 
region, B) palladin also localizes to membrane ruffles and wave-like structures. C) In 
cardiomyocytes, a prominent Z-disc staining pattern is seen, also intercalated discs 
between adjacent cells are high-lighted. D) In vascular smooth muscle (A7r5) cells 







1.4. Interaction between palladin and ezrin  
Since palladin was found in a two-hybrid screen with a carboxy-terminal ezrin bait, it 
was of interest to find out whether these proteins co-localize in cells. Ezrin usually 
localizes to plasma membrane associated structures such as microvilli and lamellipodia, 
while palladin localizes mostly to the stress fibers. When ezrin and palladin were double-
stained in HISM cells, ezrin demonstrated a filamentous staining pattern and partial co-
localization with palladin. This localization for ezrin is quite different from that in 
epithelial cells but is in line with another ERM protein, merlin, which has previously been 
shown to localize in the microfilaments. These results suggest that ezrin and palladin may 
interact in smooth muscle cells. In additional unpublished experiments, palladin and ezrin 
have been shown to co-localize also in the lamellipodia of migrating cells (Rönty et al., 
unpublished results). 
The regions mediating interaction between palladin and ezrin were mapped with the 
use of the yeast two-hybrid system. A carboxy-terminal construct of ezrin (aa 278-585) 
interacted with palladin (Ig1-3) and with a carboxy-terminal construct containing the 
second and third Ig-domains (Ig2-3), but not with a construct containing only the first Ig-
domain (Ig1). Ezrin 1-585 (wt), ezrin 1-339, and ezrin 479-585 did not interact with any of 
the constructs. The palladin binding site is thus probably masked in the dormant wild-type 
ezrin.  Further evidence for the interaction was obtained by additional experimental 
approaches. The -helical (278-531) and C-terminal (477-585) domains of ezrin were 
expressed as GST-fusion proteins and bound to glutathione beads. Lysates of yeast cells 
expressing HA-tagged palladin Ig1, Ig2-3, and the N-terminal part of ezrin (1-309) were 
incubated with beads, and bound proteins were detected with HA-antibody. Palladin Ig2-3 
bound to the -helical ezrin construct but not to the carboxy-terminus, whereas palladin 
Ig1 bound to neither ezrin construct. The two-hybrid and affinity precipitation results 
indicate that the -helical region of ezrin mediates the interaction with the carboxy-
terminal Ig-domains of palladin. 
 
The blot overlay method was used to identify whether ezrin is a major palladin-binding 
protein in cell lysates. Lysates of HISM and U251 cells, full-length ezrin, and purified 
recombinant N-terminal half of ezrin were run in SDS-PAGE, blotted on nitrocellulose 
filters, and probed with biotinylated GST-palladin Ig1-3 and GST-palladin Ig2-3. The 
palladin probes bound to denatured full-length ezrin but not to the amino-terminus; this is 
in line with the idea that the interaction site resides in the -helical region of ezrin. In cell 
lysates, both probes bound to protein bands migrating at ~63 and 75 kDa and in U251 to 
an additional band migrating at 85 kDa. Reprobing of the filters by ezrin antibody 












1.5. Expression of palladin during dendritic cell differentiation  
The differentiation of monocytes into dendritic cells (DC) is accompanied among other 
things by changes in cellular morphology. During the process, round monocytes are 
transformed into immature DCs containing filopodial projections and actin-rich 
podosomes. After final differentiation, mature DCs acquire an elongated morphology with 
dendrite-like processes. The maturation is accompanied by up-regulation of cell surface 
molecules, such as CD1a in immature DCs and CD1a and CD83 in mature DCs. We 
studied the expression and localization of palladin during the maturation process. Western 
blotting revealed that peripheral blood monocytes were devoid of palladin, whereas 
immature and mature DCs showed an immunoreactive doublet migrating at ~90-92 kDa.  
As a control, the lysates were blotted for moesin, a member of the ERM-family, which is 
expressed in the hematopoietic lineage. Unlike palladin, no differences were detected in 
the moesin expression level. Immunostaining demonstrated that in immature cells, palladin 
was concentrated in the actin-containing podosomes. In mature DCs, palladin decorated 
the thin long actin filaments. 
2. Analysis of the interaction between palladin and alpha-actinin     
(II) 
2.1. Identification of the interaction sites between palladin and α-actinin  
Palladin was shown to co-localize and co-immunoprecipitate with α-actinin by Parast 
and Otey (2000) but the interaction was not characterized in detail. We therefore set out to 
study the interaction with both in vitro and in vivo methods. Demonstration of a direct 
interaction and mapping the interaction sites was initially done with the yeast two-hydrid 
system. Several palladin inserts were cloned in the bait vector and co-transformed with α-
actinin prey constructs. In these experiments, a short segment, amino acids 222–280, 
mediated an interaction with α-actinin. None of the constructs lacking this sequence bound 
to α-actinin. The palladin binding site in α-actinin was located in the carboxy-terminal 
domain, within EF-hand domains 3–4.  
To confirm the results by another method, we performed an affinity precipitation assay 
with in vitro translated (IVT) palladin and GST-α-actinin constructs. Palladin 
polypeptides 8–772, 101–280 and 389–772 were tested with several α-actinin constructs. 
The selection of the constructs 101–280 and 389-772 was based on previous results: in our 
yeast two-hybrid analysis the binding site was mapped between amino acids 222–280, 
whereas in a previous report by Bang et al. (2001) the Ig-domains of myopalladin were 
shown to mediate the interaction, and this particular segment is homologous to palladin 
sequence 389–772.. In line with the yeast two-hybrid results, IVT products 8–772 and 







The experiments thus identified a sequence within residues 222–280 of palladin that 
was sufficient and necessary for binding of the carboxy-terminal EF-hand domains 3–4 of 
α-actinin. In myotilin, a homologous segment is located between amino acids 80-125 and 
it also mediates the interaction with α-actinin (Hauser et al., 2000). The highest homology 
between the proteins is within this sequence – particularly in a short 17 residue segment 
(64% identity and 94% similarity). This sequence does not have features of any known 
structural domain, neither do homology searches identify related sequences in 
myopalladin or any other known protein. Interestingly, this segment does seem to have an 
affinity towards calcium-binding sequences such as the EF-hand domain, since in our 
unpublished experiments we have identified other interaction partners for palladin sharing 
this motif. Also, the amino-acid substitution caused by the mutation identified by Pogue-
Geile et al. (2006) in a familiar form of pancreatic cancer maps to this segment. It is 
noteworthy that the region indicated in α-actinin binding in myopalladin (three carboxy-
terminal Ig-domains) did not mediate the interaction in palladin, although the sequences 
are 63% identical. The binding region in the EF-hand domains 3–4 of α-actinin's carboxy-
terminus is common to myopalladin, palladin and myotilin, and also titin has been shown 
to bind to the same region.  
2.2. Role of interaction sites in targeting of α-actinin and palladin  
The interaction was studied in vivo by transient transfection assays. First the 
subcellular localization of palladin constructs was analyzed. Three of these constructs (8–
772, 8–387 and 101–387) contained the α-actinin binding site identified in the biochemical 
analyses. The fourth one is a cDNA variant that contains altogether 5Ig domains but lacks 
the poly-proline sequences and also the mapped α-actinin binding site. This construct is 
part of the NM_016081 sequence accession and was cloned from a human heart cDNA 
library. It contains the two additional amino-terminal Ig-domains and is fused to 
AB023209 sequence at residue 269 (in the original article this construct was called N-Alt). 
All four constructs localized to stress fibers, but their localization displayed interesting 
differences. Only the constructs which contained the identified α-actinin binding site 
localized in dense regions, whereas N-Alt construct decorated the fibers in an even 
manner. While the reason for this difference is probably due to the fact that N-Alt did not 
bind α-actinin, the mechanism by which this construct is targeted to stress fibers remains 
so far unknown. It is possible that this construct binds directly to F-actin, since it contains 
the Ig-domains which in the homologous protein myotilin are responsible for this function 
(von Nandelstadh et al., 2005). Palladin’s ability to target endogenous and transfected α-
actinin was also studied. For this purpose we used COS cells that have a poorly arranged 
cytoskeleton devoid of stress fibers. Transfection of palladin GFP-8–772 resulted in the 
formation of thick actin bundles, a phenomenon seen also in astrocytes. Endogenous α-
actinin was partly relocated to these bundles, implying that palladin can also target α-
actinin. The transfected palladin N-alt construct formed cytoplasmic aggregates which 
contained F-actin, but α-actinin was not targeted to these structures. Interestingly, when a 






pancreatic cancer was introduced into the cells it also formed aggregates. The mutation is 
in the region that mediates the interaction with α-actinin and substitutes a single residue 
(P239S) (Pogue-Geile et al., 2006). It is possible that this mutation disrupts the interaction 
with α-actinin, but this has not been studied. Although the results described above suggest 
that the targeting of α-actinin by transfected palladin is not, at least entirely, due to re-
organization of actin, the possibility of another indirect mechanism was ruled out by 
additional experiments. This was done by cloning parts of palladin into MOM 
(Mitochondria Outer Membrane)-targeting vector (Kaufmann et al., 2000) and co-
transfecting it into cells with GFP–α-actinin lacking the actin-binding domain (R1–R4EF). 
This α-actinin construct has been shown to disrupt stress fibers and remain diffusely in the 
cytoplasm (Edlund et al., 2001). Co-transfection of R1–R4EF together with palladin 
MOM-8–387 or MOM-222–280 resulted in recruitment of the α-actinin construct from 
diffuse localization to the mitochondria, whereas the empty MOM vector failed to do so.  
All in all, these results show that palladin interacts directly with α-actinin, and that the 
proteins can target each other to the specific subcellular localization. 
3. Palladin and α-actinin interact with Abl/Arg kinase adaptor 
ArgBP2 and link it to the actin cytoskeleton (III) 
3.1. ArgBP2 interacts with palladin  
In order to identify novel interaction partners for palladin, we searched the literature 
for proteins fulfilling three requirements: (1) the protein ought to be expressed in several 
cell types including cardiomyocytes, (2) it should localize to silmilar subcellular stuctures 
as palladin, i.e., sarcomeric Z-discs and stress-fiber-dense regions and (3) it should contain 
an SH3 domain or domains, which could mediate the binding of palladin's amino-terminal 
proline-rich regions. Since ArgBP2 met all three requirements it was considered to be a 
potential interaction partner (Wang et al., 1997).  
This hypothetical interaction was first tested in a yeast two-hybrid analysis with 
several palladin and ArgBP2 constructs. In this analysis, the full-length and carboxy-
terminal SH3 domain sequences of ArgBP2 were shown to interact with the proline-rich 
amino-terminal segment of palladin. The amino-terminal ArgBP2 prey construct lacking 
the SH3 domains, did not interact with any of the palladin baits.  
 
 
3.2. Localization of ArgBP2 and palladin constructs in non-muscle cell lines 
and neonatal rat cardiomyocytes (NRC)  
In transient transfection experiments with different ArgBP2 constructs we noted an 
unexpected localization pattern. The full-length protein localized like the endogenous 
protein, i.e., to stress-fiber-dense regions and focal adhesions. This was also true for the 
carboxy-terminal part of the protein, with the exception that it localized more prominently 
to the adhesions. However, the amino-terminus of ArgBP2 without the SH3 domains also 
localized to stress fibers and adhesions. This was unexpected, since it only contains one 
domain, namely the SoHo domain, which has been shown to interact only with flotillin (a 
membrane raft associated protein) (Kimura et al., 2001). The amino-terminus also 
displayed nuclear localization in some cells, possibly due to the fact that it has previously 
been shown to contain a nuclear localization signal. As expected, double staining of co-
transfected palladin and full-length ArgBP2 demonstrated a high degree of co-localization. 
In neonatal rat cardiomyocytes, both endogenous ArgBP2 and trasfected palladin 
constructs localized to the Z-discs and intercalated discs (Figure 5). The carboxy-terminal 
ArgBP2 construct with the SH3 domains was mostly targeted to intercalated discs and less 
prominently to Z-discs. The amino-terminal construct, on the other hand, resembled the 
distribution of endogenous protein.  
Although we did not use neuronal cells in the experiments, it is interesting to note that 
both palladin and a specific ArgBP2 isoform, nArgBP2, are highly expressed in the 
nervous system where they both regulate astrocyte cytoarchitecture (Boukhelifa et al., 







Figure 5. Palladin and ArgBP2 co-transfection in cardiomyocytes. Neonatal rat 
cardiomyocytes were co-transfected with ArgBP2 and palladin constrcuts and stained 
for A) M-band Titin (blue), B) palladin (GFP-green), C) ArgBP2 (Ha-red). The 












3.3. ArgBP2 interacts with α-actinin 
The results of the transfection experiments and the previous studies, which have shown 
that Z-disc proteins often exist in multi-protein complexes, led us to investigate whether 
ArgBP2 would also interact with α-actinin. We tested this possibility with a yeast two-
hybrid analysis, in which an ArgBP2 bait construct encoding residues 25–630 was tested 
with several α-actinin prey constructs. In this assay, ArgBP2 interacted specifically with 
the amino-terminal actin-binding domain (ABD), but not with the spectrin repeat-
containing rod domain or with the carboxy-terminal EF-hand region. In addition, amino- 
and carboxy-terminal ArgBP2 prey constructs were tested with an α-actinin ABD-R1 bait 
sequence. The amino terminus of ArgBP2 showed a clear interaction, whereas the carboxy 
terminus, which interacted with palladin, did not bind α-actinin.  
3.4. Verification of the identified interactions 
Since both of the above-described interactions were novel, we needed to verify them 
with additional methods. First we used an affinity precipitation assay. In the assay in vitro 
translated (IVT) palladin was allowed to bind to individual ArgBP2 SH3 domains fused 
with GST. This assay showed that palladin binds specifically to the SH3-1 domain of 
ArgBP2, while no interaction was detected between palladin and SH3-2 or SH3-3 
domains. 
The interaction between α-actinin and ArgBP2 was verified by a similar method, 
except that α-actinin was produced in trasfected cells rather than as an IVT product. In the 
assays α-actinin bound to both ArgBP2 FL (full length) and amino-terminal constructs.  
Next, the interaction between palladin and ArgBP2 was studied in vivo with a 
mitochondrial targeting assay. Palladin MOM8-387 construct (described in the α-actinin 
article) was co-transfected with GFP constructs containing the amino- or carboxy-terminus 
of ArgBP2 to COS cells. MOM3-387 was able to target ArgBP2 carboxy terminus but not 
the amino terminus to the mitochondria.  
3.5. Palladin, α-actinin and ArgBP2 form a trimeric complex 
Since both palladin and ArgBP2 can bind to different regions of α-actinin and also to 
one another, we tested whether they can form a three-way complex. This was tested in 
vivo with an immunoprecipitation assay. COS cells were transiently co-transfected with 
HA-tagged palladin and GFP-tagged FL (full length) ArgBP2. Palladin was precipitated 
from cell lysates with an anti-HA antibody and the precipitates were immunoblotted for α-
actinin and GFP. Both α-actinin and ArgBP2 could be detected in the precipitate, 
suggesting formation of a trimeric complex. The complex was also studied with a 
transfection-based targeting assay. As shown above, over-expression of palladin in COS 
cells results in re-organization of the cytoskeleton and induction of thick actin bundles; 






behavior of the amino-terminal ArgBP2 construct co-transfected with palladin. The 
amino-terminal ArgBP2 fragment was also targeted to the bundles in analogy with α-
actinin, although this fragment does not bind to palladin. Since this ArgBP2 fragment 
binds to α-actinin, the result implies that a complex of the three proteins might exist in 
vivo in line with the results of the precipitation assay.  
Taken together, our results identified ArgBP2 as a palladin-interacting protein, and 
showed that ArgBP2 also binds to α-actinin. Furthermore, a complex of the three proteins 
was identified in vivo. 
4. Palladin interacts with SPIN90 and Src and is involved in Src-
induced cytoskeletal remodeling (IV) 
4.1. Palladin interacts with the SH3 domains of SPIN90 and Src  
SPIN90 was identified as a potential palladin-binding protein with the same rationale 
that was used for ArgBP2: it is an actin-cytoskeleton-associated protein with SH3 
domain(s) and a wide tissue distribution including cardiomyocytes. In the original 
publication characterizing SPIN90, its SH3 domain was shown to have highest homology 
(35% identity and 50% similarity) with the SH3 domains of Fyn, Yes, and c-Src (Lim et 
al., 2001). Since Src is known to regulate actin cytoskeleton and has been shown to 
phosphorylate SPIN90 we also included it in these analyses. Furthermore, in the first 
paper characterizing palladin it was proposed to be a phosphoprotein, although no 
experimental evidence was shown in order to verify this  (Parast and Otey, 2000).  
The interactions were characterized essentially in a similar way as with ArgBP2, and 
are therefore described only briefly here. First, we used the yeast two-hybrid system, and 
found that both SPIN90 and Src SH3 domains interacted with the amino-terminal proline-
rich segment of palladin (3Ig isoform). The preliminary results were then verified with an 
affinity precipitation assay. The results showed that the segments identified in the yeast 
two-hybrid assay indeed mediated the interactions. Also, palladin and SPIN90 could be 
co-immunoprecipitated from lysates of co-transfected cells. In vivo, the interaction was 
shown by targeting assays. Trasfected SPIN90 co-localized to palladin-induced actin 
bundles in COS cells and also to the outer mitochondrial membrane in cells transfected 
with the previously described palladin MOM-construct (8-228).  
4.2. The effect of PDGF treatment and activation of the Src-kinase on 
palladin and SPIN90 localization  
Both palladin and SPIN90 have been shown to localize to PDGF-induced membrane 
ruffles and lamellipodia (Goicoechea et al., 2006; Kim et al., 2006). Since the effects of 






affect palladin and SPIN90 distribution in U251 glioma cells. Under basal conditions 
palladin localized, as previously described, to stress-fiber-dense regions, while SPIN90 
showed a diffuse cytoplasmic distribution. PDGF treatment led to a rapid re-distribution of 
both proteins to the newly formed membrane ruffles and wave-like actin-based structures. 
These effects were abolished by addition of the selective Src-kinase family inhibitor PP2. 
Although we did not study the localization of palladin and SPIN90 in neural cells, it is 
of interest that both proteins have been shown to localize predominantly in the presynaptic 
compartment of neurons. In the synapses, palladin co-localizes with vesicle protein 
synaptophysin (Hwang et al., 2001), and SPIN90 has been shown to be involved in 
synaptic vesicle endocytosis (Kim et al., 2005). These findings point to the possibility that 
the proteins might interact also in the synapses, but this hypothesis needs to be verified 
experimentally. 
 When the cells were transfected with an active (CA) Src construct, both SPIN90 and 
palladin rapidly re-localized to the Src-induced actin-rich membrane protrusions. SPIN90 
has been previously linked directly to Src-induced cytoskeletal rearrangements (see below 
and Introduction) and our results suggest that also palladin plays a part in this process. 
4.3. Palladin is required for Src-induced actin remodeling  
Previously the knock-down of both palladin and SPIN90 by specific siRNAs has been 
shown to inhibit PDGF-induced membrane ruffle formation (Goicoechea et al., 2006; Kim 
et al., 2006). We wanted to examine whether this is true also for Src-kinase-induced actin 
remodeling. U251 cells were co-transfected with active Src and either with SPIN90-
specific siRNA construct or with a palladin-specific siRNA oligonucleotide. The down-
regulation of SPIN90 did not result in detectable cytoskeletal alterations, and the SrcCA-
induced rearrangement appeared normal. This is in line with previous results which show 
that, although SPIN90 is a Src substrate and targets effector proteins Vav2 and 
p190RhoGAP to the plasma membrane, it is not needed for Src re-location and initiation 
of the cytoskeletal remodeling (Meng et al., 2004). However, when palladin was knocked 
down, the cells lost stress fibers, became more rounded, and the effects of SrcCA on the 
actin cytoskeleton were inhibited. Fewer membrane protrusions were formed in cells co-
transfected with palladin siRNA and SrcCA, and the localization of Src, SPIN90 and 
cortactin remained diffuse. Activation-induced Src re-localization has been shown to 
require intact stress fibers and it is mediated by the SH3 domain (Fincham et al., 1996; 
Fincham et al., 2000). Together, these results offer a basis for a model in which Src and 
SPIN90 translocate after stimulation to the membrane via a palladin/stress-fiber-dependent 
manner. The re-localization is mediated by the interactions between the SH3 domains and 
palladin. Subsequently, Src phosphorylates p190RhoGAP and Vav2 via SPIN90, leading 
to  Rho inactivation and Rac activation. This results in a loss of stress fibers and formation 
of lamellipodia.  
4.4. Phosphorylation of palladin in Src CA-transfected cells  
In order to characterize the interplay between palladin and Src in more detail, we also 
tested whether palladin is phosphorylated in a Src-dependent manner, as previously shown 
for SPIN90. Co-expression with SrcCA resulted in tyrosine phosphorylation of palladin, 
as verified by blotting of immunoprecipitated palladin with phospho-tyrosine antibody. 
Whether palladin is a direct Src substrate remains to be tested, and the phosphorylated 
tyrosine residues need still to be identified. However, this is the first published result 
showing that palladin is indeed phosphorylated on tyrosine, and that it also identifies Src 









Figure 6. Palladin-interacting proteins and the rough localization of the interaction sites are 
summarized in the figure.All the interacting sequences identified in the shorter palladin 


















Table 1. Palladin-interacting proteins 
The published palladin-interacting proteins and some identified but unpublished    binding 
partners and their binding sites in palladin. 
 
Interacting protein Interaction site in palladin Reference 
α-actinin between amino acids 222-280, Parast & Otey, 2000 
 human 3Ig  isoform Rönty et al.,2004 
VASP FPXPP motifs in mouse 3Ig and 
4Ig isoforms 
Boukhelifa et al., 2004 
Ezrin 2 carboxy-terminal IgC2 
domains of  human palladin 
Mykkänen et al., 2001 
ArgBP2 amino-terminal poly-proline 
sequence of human 3Ig isoform 
Rönty et al., 2005 
Profilin  amino-terminal poly-proline 
sequences of human and mouse  
3Ig isoforms 
Boukhelifa et al., 2006 
Lipoma-preferred partner (LPP) between amino-acids 1-81, 
mouse 3Ig isoform 
Jin et al.,.2007 
Eps8 amino-terminal poly-proline 
sequence of mouse 3Ig isoform 
Goicoechea et al.,.2006 
LASP-1 amino-terminal poly-proline 
sequence of mouse 4Ig isoform 
Rachlin et al., 2006 
Integrin αvβ5 between amino acids 298-772 
of human 3Ig isoform 
Lai et al., 2006 
SPIN90 and Src 
 
amino-terminal poly-proline 
sequences of human 3Ig 
isoform 
Rönty et al., 2007 
Arp2/3, ABP280 ? Luo et al., 2005  
(unpublished) 
CIB, Snk, Copine between amino acids 222-772 
of human 3Ig isoform 
Rönty et al. (unpublished) 
GIT1 amino terminus of human 5Ig 
isoform 












5. Palladin expression is regulated in an isoform-specific manner 
during TGF-β1-induced myofibroblast differentiation (V)  
5.1. Characterization of isoform-specific palladin antibodies 
Previous studies on both humans and especially on mice have shown that palladin is 
expressed as multiple differentially sized isoforms (Mykkanen et al., 2001; Parast and 
Otey, 2000; Rachlin and Otey, 2006). The two major isoforms are called 3Ig (90kDa) and 
4Ig (140kDa), since they contain 3 and 4 IgC2 type domains, respectively. According to 
previous results, both isoforms are expressed in U251 human glioma cells, and therefore 
U251 mRNA was used as a template to clone the 5'-sequence extension of the human 4Ig 
homologue by RT-PCR. In order to study the expression and localization of the various 
palladin isoforms, we raised two polyclonal antibodies against different palladin 
polypeptides. For antibody 3Ig (Ab-3Ig), a proline-rich amino-terminal segment of the 
Ab023209 sequence was used as antigen. The 4Ig (Ab-4Ig-Hu) antigen is the cloning 
product of the RT-PCR reaction described above. The reactivity/specificity of the new 
antibodies was verified by Western blot analysis of both native and palladin-transfected 
cells and by comparing the results obtained with a panel of previously described 
antibodies (Ab-4Ig-Mo, Ab953 and a mixture of palladin mAbs [4D10, 7C6, 9C12, and 
1E6]). Both new antibodies recognized the transfected protein containing the specific 
antigen sequence and no cross-reactivity was detected. In U251 cells the antibodies 
reacted with several protein bands, one of which (140 kDa) was recognized by all 
antibodies used, thus verifying that the 4Ig sequence is expressed and recognized by the 
new antibodies. The previously described 3Ig (90 kDa) major isoform was recognized by 
Ab-3Ig, Ab953, and the mAb, but not by either 4Ig antibody. In conclusion, Ab-3Ig 
recognizes both the 3Ig and 4Ig isoforms, whereas the 4Ig antibodies react with the 4Ig but 
not the 3Ig isoform. In U251 cells the antibodies detected also some additional bands, 
which probably present additional differentially spliced transcripts. The immunostaining 
patterns of the 3Ig and 4Ig were similar in these cells. 
5.2. Regulation of palladin expression during myofibroblastic differentiation 
As many cytoskeletal proteins are up-regulated during TGF-β1-induced myofibroblast 
differentiation (Malmstrom et al., 2004), we set out to study whether this is the case also 
for palladin. First, we stained normal dermal fibroblasts with Ab-3Ig and Ab-4Ig-Hu 
antibodies. Ab 3Ig stained stress-fiber-dense regions and focal adhesions of fibroblasts, 
whereas Ab 4Ig-Hu did not show specific reactivity. When the cells were treated with 
TGF-β1 (5 ng/ml) for 12–96 hours, the staining pattern of the 3Ig isoform remained 
similar, but the staining became more intense. After the treatment, also Ab-4Ig-Hu showed 
a distinctive punctate stress-fiber staining, thus indicating that TGF-β1 induces neo-
expression of the 4Ig isoform. As shown in numerous previous studies, SMA was also 






localized with palladin in stress fibers. Western blots of fibroblasts at different time points 
during the TGF-β1 treatment gave a similar result: upregulation of the 3Ig isoform and 
neo-expression of the 4Ig isoform. The 4Ig isoform was rapidly up-regulated by about 24 
hours before the induction of α-SMA. 
5.3. TGF-β1 -induced palladin expression is mediated by Smad3, p38, and 
ERK1/2 
In order to investigate the role of the Smad and MAPK signaling cascades in the 
regulation of palladin expression, we utilized an adenoviral gene delivery method. An 
adenovirus construct of Smad3 (RAdSmad3) was used to achieve overexpression of 
Smad3. Dominant-negative Smad3 (RAdSmad3DN) and inhibitory Smad7 (RAdSmad7) 
were applied to inhibit Smad signaling. Fibroblasts were infected with the different Smad 
adenoviruses and treated with TGF-β1 (5 ng/ml) for 24 h. Over-expression of Smad3 
enhanced the TGF-β1 -induced palladin expression, whereas the inhibitory Smad3DN and 
Smad7 had an opposite effect. The expression pattern of SMA was similar to that of 
palladin. 
TGF-β1 has been shown to activate both ERK1/2 and p38 MAPK pathways in 
fibroblasts, and there is considerable cross-talk between the Smad and MAPK signaling 
cascades (Leivonen et al., 2002; Leivonen et al., 2005). Taking this into account, we 
checked whether ERK1/2 and p38 MAPK pathways also play a part in the regulation of 
palladin expression. We therefore used specific chemical inhibitors of MEK1 (the 
upstream activator of ERK1/2) and p38. Both PD98059, which inhibits  MEK1, and 
SB203580, an inhibitor of p38, downregulated TGF-β1-induced palladin expression, 
implying that both members of the MAPK signaling cascades are involved in mediating 
the effects of TGF-β1 on palladin gene expression. Similar effects were also observed for 
SMA. 
Finally, simultaneous effects of activation/inhibition of the Smad and MAPK pathways 
were studied. Fibroblasts were infected with different combinations of adenoviruses 
encoding Smad3, Smad4, wild-type p38α (RAdp38α) and constitutively active MKK3b 
(RAdMKK3bE), an upstream activator of p38. Activation of p38 by MKK3b induced the 
expression of palladin 4Ig, and this effect was further enhanced by Smad3. In addition, 
activation of ERK1/2 with co-expression of Smad3 resulted in marked induction in 
palladin 4Ig isoform expression, and this effect was further enhanced by co-expression of 
constitutively active MKK3b. Together, these results imply that the interplay between 
ERK1/2, p38, and Smad3 signaling plays an important role in regulating palladin gene 
expression. 
5.4. Palladin is expressed in experimental rat dermal wounds 
To verify the in vitro results in vivo, we used an experimental rat dermal wound model. 
Frozen sections of 3-, 6- and 9-day-old granulation tissue from rat dermal wounds were 
stained with SMA, palladin 4Ig (Ab-4Ig-Mo) and palladin 3Ig antibodies. Palladin 4Ig 
was not expressed in the early stages of granulation tissue formation (3 days) but neo-
expression by the fibroblasts was detected at day 6 post wounding. At this stage the 
fibroblasts were still negative for SMA and thus represent the proto-myofibroblast 
phenotype (see section on myofibroblasts). At day 9, the fibroblasts were already 
differentiated into mature myofibroblasts and expressed both SMA and palladin 4Ig. The 
findings are in agreement with the in vitro results, and verify that palladin is indeed up-
regulated during myofibroblast differentiation. 
5.5. Analysis of palladin expression in vivo in human tissue samples 
The in vivo expression of palladin was also studied by immunohistochemical staining 
of human tissue specimens. For this purpose we chose samples from conditions associated 
with myofibroblastic differentiation, including fresh dermal scar and nodular fasciitis 
(Dayan et al., 2005). Subsequent sections of each entity were stained for α-SMA, desmin, 
and with two palladin antibodies: Ab-4Ig-Mo and Ab-3Ig. A clear correlation between α-
SMA and palladin stainings could be detected, whereas desmin did not stain the 
myofibroblasts. In normal dermis the fibroblasts did not express palladin, desmin, or α-
SMA. A myofibroblastic breast tumor was also stained with this antibody panel with 
similar results. Interestingly, the normal ductal myoepithelial cells included in the 
specimen showed  a clear positivity for palladin 4Ig (Figure 7). This unpublished result 
further strengthens the correlation between palladin 4Ig and α-SMA expression, since the 





Figure 7. Breast tissue stained with A) palladin, B) SMA and C) desmin 
antibodies.Palladin and SMA are expressed by the myoepithelial cells lining the ductules, 














This study describes the identification and initial characterization of human palladin, a 
microfilament-associated protein. Together with myotilin and myopalladin, palladin forms 
a novel cytoskeletal Ig-domain protein family. Although the family members share 
similarities, such as sub-cellular localization and interaction with α-actinin, there are also 
important differences among them. Unlike myotilin and myopalladin, palladin’s 
expression is not limited to striated muscle, and it is ubiquitously expressed. Palladin has a 
very complex genetic structure giving rise to multiple differentially spliced transcripts 
with differing structure, tissue distribution, binding partners, and most probably function.  
Knock-down experiments and the generation of palladin knock-out mouse have shown 
that palladin has an important role in the organization and stabilization of actin stress 
fibers and possibly other actin-based structures, such as podosomes. It seems to play an 
important role in cell migration as well. Expression of palladin can be regulated by 
multiple mechanisms, and it seems that palladin is usually up-regulated in situations 
requiring a more organized actin cytoskeleton, for example, during activation of astrocytes 
in glial scar formation and during myofibroblast differentiation.  
In this study we identified novel interactions between palladin and ezrin, ArgBp2, 
SPIN90 and Src. Furthermore, the previously identified interaction with α-actinin was 
characterized in more detail. The interaction with α-actinin probably serves to enhance the 
stability of the stress fibers and other actin-based structures where these two proteins co-
exist. The interaction also seems to have a two-way targeting function, meaning that both 
proteins can target each other to the right location.  
Both palladin and α-actinin probably act as molecular scaffolds that link proteins with 
different functional modalities to the cytoskeleton. The function of the other identified 
interactions is still mostly unknown. Ezrin, ArgBP2 and SPIN90 are all involved in actin 
cytoskeleton regulation and interact also with effectors such as kinases. Ezrin links plasma 
membrane to the cytoskeleton, and the interaction with palladin may enhance this linkage. 
Contrary to what was suggested in the intial study, ezrin and palladin co-localize and 
probably interact mostly in the lamellipodia of migrating cells and not in the stress fibers, 
since ezrin only rarely localizes to these structures. SPIN90 and ArgBP2 are scaffolding 
proteins like palladin, and the interactions may serve to target these proteins to specific 
locations such as Z-disc in the case of ArgBP2. The interaction between Src and palladin 
is interesting and warrants further characterization. Already in the initial report by Parast 
and Otey, palladin was considered to be a phosphoprotein, but no experimental data to 
verify this has been presented. We showed that palladin is indeed phosphorylated on 
tyrosine in cells expressing active Src, but here again the function of this phenomenon 
remains to be seen. 
The finding that has probably the most direct clinical implications is the up-regulation 
of palladin expression in myofibroblast differentiation. Palladin expression correlates 
closely with SMA, which is a known mediator of myofibroblast contraction and thus 
implicated in tissue remodeling in fibrotic lesions. Palladin is probably also involved in 






showed that palladin expression is mediated both by SMAD and MAPK pathways; this is 
also true for SMA. The inhibition of these signaling cascades is a potential therapeutic 
target of anti-fibrotic treatment. In this sense the elucidation of palladin’s role in 
conditions such as idiopathic pulmonary fibrosis is particularly interesting. 
So far palladin mutations/SNPs have been detected in two disease conditions. This list 
will probably grow in the future, and also the function of the already identified mutations 
will be investigated. Since the complete genetic knock-out of palladin results in the death 
of the developing embryos, the generation of a conditional knock-out mouse model is 
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